<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Oncol</journal-id><journal-id journal-id-type="iso-abbrev">Front Oncol</journal-id><journal-id journal-id-type="publisher-id">Front. Oncol.</journal-id><journal-title-group><journal-title>Frontiers in Oncology</journal-title></journal-title-group><issn pub-type="epub">2234-943X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7251173</article-id><article-id pub-id-type="doi">10.3389/fonc.2020.00787</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oncology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Biomechanical Contributions to Macrophage Activation in the Tumor Microenvironment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hoffmann</surname><given-names>Erica J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/827915/overview"/></contrib><contrib contrib-type="author"><name><surname>Ponik</surname><given-names>Suzanne M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/828037/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Cell and Regenerative Biology, Wisconsin Institutes for Medical Research, University of Wisconsin-Madison</institution>, <addr-line>Madison, WI</addr-line>, <country>United States</country></aff><aff id="aff2"><sup>2</sup><institution>University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison</institution>, <addr-line>Madison, WI</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Panagiota S. Filippou, Teesside University, United Kingdom</p></fn><fn fn-type="edited-by"><p>Reviewed by: Jo A. Van Ginderachter, Vrije University Brussel, Belgium; Till Adhikary, University of Marburg, Germany</p></fn><corresp id="c001">*Correspondence: Suzanne M. Ponik <email>ponik@wisc.edu</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology</p></fn></author-notes><pub-date pub-type="epub"><day>20</day><month>5</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>10</volume><elocation-id>787</elocation-id><history><date date-type="received"><day>15</day><month>1</month><year>2020</year></date><date date-type="accepted"><day>22</day><month>4</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Hoffmann and Ponik.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Hoffmann and Ponik</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Alterations in extracellular matrix composition and organization are known to promote tumor growth and metastatic progression in breast cancer through interactions with tumor cells as well as stromal cell populations. Macrophages display a spectrum of behaviors from tumor-suppressive to tumor-promoting, and their function is spatially and temporally dependent upon integrated signals from the tumor microenvironment including, but not limited to, cytokines, metabolites, and hypoxia. Through years of investigation, the specific biochemical cues that recruit and activate tumor-promoting macrophage functions within the tumor microenvironment are becoming clear. In contrast, the impact of biomechanical stimuli on macrophage activation has been largely underappreciated, however there is a growing body of evidence that physical cues from the extracellular matrix can influence macrophage migration and behavior. While the complex, heterogeneous nature of the extracellular matrix and the transient nature of macrophage activation make studying macrophages in their native tumor microenvironment challenging, this review highlights the importance of investigating how the extracellular matrix directly and indirectly impacts tumor-associated macrophage activation. Additionally, recent advances in investigating macrophages in the tumor microenvironment and future directions regarding mechano-immunomodulation in cancer will also be discussed.</p></abstract><kwd-group><kwd>macrophage activation</kwd><kwd>breast cancer</kwd><kwd>extracellular matrix</kwd><kwd>tumor microenvironment</kwd><kwd>integrins</kwd><kwd>collagen</kwd><kwd>mechanosensing</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source><award-id rid="cn001">R01CA216248</award-id></award-group></funding-group><counts><fig-count count="2"/><table-count count="1"/><equation-count count="0"/><ref-count count="127"/><page-count count="11"/><word-count count="8231"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Macrophages are an innate immune cell type found in all tissues of the body with multiple functions. Tissue resident pools of macrophages arise from embryonic tissues during development, and are critical for normal tissue morphogenesis (<xref rid="B1" ref-type="bibr">1</xref>). During homeostasis, tissue macrophages are maintained primarily through local proliferation. In chronic inflammatory processes such as cancer, hematopoietic derived monocytes circulate through the blood and infiltrate tissues where they terminally differentiate into macrophages to, in part, replenish resident pools as well as increase macrophage levels for the remediation of infection or structural damage (<xref rid="B2" ref-type="bibr">2</xref>). Macrophages display a spectrum of opposing yet complementary behaviors depending on the signals they receive from the local microenvironment (<xref rid="B3" ref-type="bibr">3</xref>). Traditionally, macrophage activation has been characterized using a dichotomous spectrum, with the two extremes being &#x0201c;classically activated&#x0201d; or pro-inflammatory macrophages and &#x0201c;alternatively activated&#x0201d; or pro-remodeling, immunosuppressive macrophages. Classically activated macrophages (termed M1) phagocytize microbes and secrete cytokines such as interleukin 6 (IL-6), TNF-&#x003b1;, and IL-1&#x003b2;, as well as nitric oxide (NO) and reactive oxygen species during host defense in response to stimulation by interferon-&#x003b3; (IFN-&#x003b3;) and toll-like receptor ligands, including bacterial lipopolysaccharide (LPS). Alternatively activated macrophages (termed M2) are stimulated primarily by the T<sub>h</sub>2 cytokines IL-4 and IL-13 and facilitate extracellular matrix (ECM) remodeling, blood vessel formation, and dampen immune activation by secreting cytokines such as IL-10 and TGF-&#x003b2; (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). In recent years it has become apparent that the dichotomous M1/M2 model is an oversimplification of the behavioral spectrum of macrophages, with many unique transcriptional profiles being identified in response to differing activation signals (<xref rid="B6" ref-type="bibr">6</xref>). As such, it is now recommended to denote macrophage states by the activating stimulus (e.g., M<sub>LPS+IFN&#x003b3;</sub> or M<sub>IL4+IL13</sub>) (<xref rid="B7" ref-type="bibr">7</xref>). Macrophage activation states have been characterized extensively in murine and <italic>in vitro</italic> models. However, the exact genetic profiles and functional outputs, such as NO production (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>), for example, differ from human macrophage states and the relevance of murine studies to human macrophage biology is still under debate. Nonetheless, both major macrophage phenotypes are required for maintaining tissue homeostasis, but each, respectively, can play a role in the pathogenesis of diseases including atherosclerosis and cancer (<xref rid="B10" ref-type="bibr">10</xref>).</p></sec><sec id="s2"><title>Macrophages and the Extracellular Matrix in Cancer</title><p>In cancer, macrophages infiltrate the tumor microenvironment (TME) in response to tumor-secreted chemotactic signals and exhibit a tumor-supportive phenotype similar to the M2 phenotype. High macrophage infiltration has been associated with a poor prognosis and increased rates of metastasis in several cancer types, as tumor-associated macrophages (TAMs) can facilitate blood vessel formation to support expanding tumor growth and aid tumor cell intravasation into vasculature (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>). Much work has been done to characterize soluble factors present in the TME that recruit and influence macrophage behavior (<xref rid="B14" ref-type="bibr">14</xref>), however less is known about how the mechanical properties of tumor ECM impact macrophage recruitment, activation, and cytokine secretion.</p><p>Many cancers, including breast cancer, exhibit aberrant deposition, and organization of extracellular matrix proteins surrounding a tumor (<xref rid="B15" ref-type="bibr">15</xref>&#x02013;<xref rid="B18" ref-type="bibr">18</xref>). The ECM is comprised of several fibrous and non-fibrous proteins including collagens, laminins, fibronectin, and others that are deposited and organized into a stromal meshwork that supports cellular growth and migration. Indeed, dense breast tissue is a strong and prevalent risk factor for the development of invasive breast cancer and is associated with excess collagen deposition and tissue stiffness (<xref rid="B19" ref-type="bibr">19</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>). Recent studies demonstrate that even in healthy patients, mammographically dense tissue increases pro-tumor inflammation and overall immune infiltration, including CD68+ macrophages and CD20+ B lymphocytes surrounding the vasculature, which may be part of the underly mechanism driving this risk of developing breast cancer (<xref rid="B24" ref-type="bibr">24</xref>). In breast cancer patients, the reorganization of collagen that accompanies tumor progression results in aligned fiber bundles at the tumor-stromal boundary and, importantly, this signature of collagen predicts disease outcome (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B25" ref-type="bibr">25</xref>). Along these lines, in invasive ductal carcinoma biopsy tissue, the association of anti-inflammatory CD163+ macrophages and aligned collagen fibers is predictive of poor patient outcome (<xref rid="B26" ref-type="bibr">26</xref>). Macrophages have been shown to play a role in matrix organization through the secretion of matrix metalloproteinases to degrade and reorganize the matrix as well as aid in tumor cell migration (<xref rid="B27" ref-type="bibr">27</xref>). Moreover, tumor associated macrophages have been shown to facilitate the deposition of aligned collagen fibers during tumor development (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>).</p><p>As monocytes circulate toward tumor signals they encounter soluble plasma matrix proteins, such as fibronectin and fibrinogen, known to be upregulated in breast cancer patients and associated with poor prognosis (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). The binding of these ECM proteins to adhesion receptors on the surface of macrophages promote inflammatory and tumor-promoting macrophage activation (<xref rid="B32" ref-type="bibr">32</xref>&#x02013;<xref rid="B34" ref-type="bibr">34</xref>) (<xref ref-type="fig" rid="F1">Figure 1A</xref>). Within tumor stroma, collagen along with fibronectin and laminin have been shown to promote tumor cell proliferation, angiogenesis, and dissemination (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>). Alterations in ECM organization and composition in the tumor microenvironment result in increased matrix stiffness, primarily localized to the invasive front of breast tumors. These stiff regions are enriched in aligned collagen fibers, tumor-activated macrophages (CD163+) and the activated form of &#x003b2;1-integrin (<xref rid="B23" ref-type="bibr">23</xref>). Similarly, accelerated tumor progression was accompanied by an overall increase in macrophages and tumor cytokines, including CCL2, in a collagen-dense mammary tumor model compared to controls (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>). Moreover, CCL2 recruits Tie2 expressing macrophages to facilitate early tumor cell dissemination (<xref rid="B39" ref-type="bibr">39</xref>). This process involves a mechanism by which macrophages lead tumor cells through reciprocal chemokine signaling along collagen coated substrates and toward vascular endothelium <italic>in vitro</italic>. Importantly, the same mechanism of macrophage-tumor cell migration has been observed <italic>in vivo</italic>, where macrophage-tumor cell trafficking can be visualized along collagen fibers (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). Together, these studies suggest that matrix stiffness increases CCL2 levels, which in turn recruits specific macrophage populations that interact with collagen fibers and facilitate tumor cell dissemination. Thus, it is becoming clear that macrophages are sensitive to changes in the ECM and their mechanical environment, however the causal link between ECM biophysical properties and the functional activation of TAMs <italic>in vivo</italic>, in animal models as well as in humans, is still unclear.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Schematic of biophysical cues from the ECM to activate integrin signaling on macrophages in the TME. <bold>(A)</bold> Inset depicts integrins on the surface of monocytes within the lumen of a blood vessel. Integrin engagement activates monocytes in circulation and facilities transendothelial migration into the TME. <bold>(B)</bold> Macrophage localized in a region of increasing matrix stiffness. Matrix stiffness results in integrin clustering and focal adhesion signaling. Downstream of integrins there is an increase in the PI3K/Akt pathway to activate NF-kB transcriptional activity as well as actin/myosin generated cellular contractility leading to directional migration. Further investigation is required to determine whether integrin signaling regulates other markers of macrophage activation.</p></caption><graphic xlink:href="fonc-10-00787-g0001"/></fig></sec><sec id="s3"><title>Mechanical Regulation of Macrophage Polarization</title><p>Growing appreciation for biophysical cues from the extracellular matrix to drive cellular phenotypes has led to a large body of work demonstrating that ECM topography, composition, stiffness, and other mechanical loading modalities are capable of modulating macrophage function <italic>in vitro</italic>. The field of macrophage mechanobiology has largely stemmed from the biomaterials and implant fields. These fields have found that changing surface topography by increasing surface roughness generally results in increased macrophage adhesion and alterations in cytokine secretion, but the mechanisms by which roughness impacts macrophage responses depends on the method and the macrophage cell types used for investigation (<xref rid="B42" ref-type="bibr">42</xref>&#x02013;<xref rid="B44" ref-type="bibr">44</xref>). Other studies have demonstrated that substrate stiffness, which is associated with enhanced breast tumor progression, is another mechanical aspect of the ECM that can influence macrophage behavior (<xref ref-type="fig" rid="F1">Figure 1</xref>). Increasing the stiffness of biologic and engineered substrates resulted in increased migration of unstimulated macrophages, and inflammatory macrophage cytokine production (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). However, it should be noted that these increases are accompanied by altered integrin expression levels as well as increased myeloid differentiation response protein 88 (MyD88)-dependent NF-&#x003ba;B activation through TLR activation, and that NF-&#x003ba;B has been shown to regulate anti-inflammatory gene expression as well (<xref rid="B47" ref-type="bibr">47</xref>). Additionally, these effects are independent of collagen I and laminin stimulation and may be the result of cytoskeletal signaling rather than integrin engagement.</p><p>Changes in cell shape and the cytoskeleton are also frequently observed with increasing substrate stiffness and can in themselves alter macrophage activation. In general, M1 macrophages are uniformly spread, with a circular morphology (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B48" ref-type="bibr">48</xref>). Inflammatory activation is inhibited when bone marrow derived macrophages (BMDMs) are confined to small pores rather than allowed to spread freely, through a mechanism involving actin dynamics and signaling through the MRTF-A-SRF complex (<xref rid="B49" ref-type="bibr">49</xref>). However, elongation of macrophages produces a different phenotype. Macrophages elongated on 2-D engineered nano-substrates consistently correlates with anti-inflammatory gene expression profiles across a variety of surfaces and cell lines at late time points (&#x0003e;24 h) and when cells are allowed to spread along wider grooves (&#x0003e;450 nm widths). Furthermore, macrophage elongation increases expression of adhesion receptors, actin-based contraction and enhances activation by IL-4/IL-13, while preventing elongation attenuates these cytokines' ability to activate the macrophages (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>).</p><p>In many of these studies, it appears that mechanical stimuli may work in conjunction with soluble factors to induce macrophage activation. Nevertheless, mechanical stimulation likely plays an equally important role in priming macrophages to become activated toward a specific phenotype, however the exact cellular mechanisms and intracellular signaling pathways that mediate this still require further investigation. Therapeutically, there is potential to modulate macrophage behavior via mechanical regulation, however the application of this knowledge in the context of cancer remains limited, as more work is required to characterize the mechanical dynamics present within the TME. Presently, there are few therapies that directly target ECM stiffness or organization. Therefore, understanding how the ECM can modulate the activity of soluble signals on macrophages in the TME, through adhesion receptors and the cytoskeleton for example, may provide insights into improving existing therapies that target cytokine and growth factor signaling.</p></sec><sec id="s4"><title>Integrin Adhesion Signaling in Macrophage Activation</title><sec><title>Overview</title><p>As previously eluded to, mechanical cues from the ECM can be detected by macrophages through the integrin family of heterodimeric adhesion receptors, and many integrins are differentially expressed by classically and alternatively activated macrophages (<xref rid="B45" ref-type="bibr">45</xref>). Integrins consist of an alpha and beta subunit. Each alpha and beta combination has a unique binding affinity for certain matrix proteins, however each integrin often has multiple ECM ligands. Upon ligand binding, integrins transduce signals inside of the cell via adapter proteins such as focal adhesion kinase (FAK), talin, vinculin, and others that couple integrins to the cytoskeleton (outside-in signaling) (<xref rid="B52" ref-type="bibr">52</xref>). Changes in cytoskeletal organization have a direct impact on several transcription factors, including MRTF-A, YAP and NF-&#x003ba;B, which facilitate changes in gene transcription that are potentially related to macrophage function. Several integrins are expressed by macrophages (<xref rid="T1" ref-type="table">Table 1</xref>), the most common being the &#x003b2;2 family of integrins which are unique to leukocytes. Although integrin signaling has traditionally been overlooked when investigating macrophage activation, several studies have demonstrated that integrin-ECM adhesion initiates signaling pathways that can in fact influence macrophage activation. Based on these studies the concept emerges that biophysical cues from the ECM regulate macrophage activation, in part, through integrin engagement and signaling (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Integrins expressed on the surface of murine macrophages.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1"><bold>Integrin</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>ECM Ligands</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Other ligands</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Main functions</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003b2;2 Family</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x003b1;L&#x003b2;2</bold><break/> CD11a/CD18<break/> LFA-1</td><td valign="top" align="left" rowspan="1" colspan="1">None.</td><td valign="top" align="left" rowspan="1" colspan="1">ICAM-1 ICAM-3 ICAM-2 ICAM-5 JAM-1</td><td valign="top" align="left" rowspan="1" colspan="1">Endothelial transmigrationIntercellular adhesion</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B53" ref-type="bibr">53</xref>&#x02013;<xref rid="B56" ref-type="bibr">56</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x003b1;M&#x003b2;2</bold><break/> CD11b/CD18<break/> Mac-1 CR3</td><td valign="top" align="left" rowspan="1" colspan="1">Fibronectin Vitronectin Fibrinogen Laminins Collagens Cyr61</td><td valign="top" align="left" rowspan="1" colspan="1">ICAM-1<break/> ICAM-2<break/> ICAM-3<break/> iC3b<break/> Thrombospondin<break/> CD23<break/> NIF<break/> LPS<break/> [for complete list please see (<xref rid="B57" ref-type="bibr">57</xref>)]</td><td valign="top" align="left" rowspan="1" colspan="1">Migration<break/> Complement Receptor Type 3<break/> Phagocytosis<break/> Trans-endothelial extravasation</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B57" ref-type="bibr">57</xref>&#x02013;<xref rid="B60" ref-type="bibr">60</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x003b1;X&#x003b2;2</bold><break/> CD11c/CD18<break/> P150,95<break/> CR4</td><td valign="top" align="left" rowspan="1" colspan="1">Fibrinogen</td><td valign="top" align="left" rowspan="1" colspan="1">ICAM-1<break/> ICAM-4<break/> CD23<break/> LPS<break/> Thy-1<break/> iC3b<break/> Plasminogen</td><td valign="top" align="left" rowspan="1" colspan="1">Complement Receptor Type 4<break/> Intercellular adhesion<break/> Fibrinogen adhesion</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B60" ref-type="bibr">60</xref>&#x02013;<xref rid="B67" ref-type="bibr">67</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x003b1;D&#x003b2;2</bold><break/> CD11d/CD18</td><td valign="top" align="left" rowspan="1" colspan="1">Fibronectin Vitronectin Fibrinogen<break/> Cyr61</td><td valign="top" align="left" rowspan="1" colspan="1">ICAM-3<break/> Plasminogen<break/> P2-C</td><td valign="top" align="left" rowspan="1" colspan="1">Migration<break/> Cell adhesion</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B68" ref-type="bibr">68</xref>&#x02013;<xref rid="B70" ref-type="bibr">70</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003b2;1 Family</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x003b1;2&#x003b2;1</bold><break/>
<italic>VLA-2</italic><break/>
<italic>CD49b/CD29</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Collagens Laminins</td><td valign="top" align="left" rowspan="1" colspan="1">Echovirus 1</td><td valign="top" align="left" rowspan="1" colspan="1">Migration<break/> Cell adhesion</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B71" ref-type="bibr">71</xref>&#x02013;<xref rid="B73" ref-type="bibr">73</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x003b1;4&#x003b2;1</bold><break/>
<italic>VLA-4</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Fibronectin<break/> EMILIN1</td><td valign="top" align="left" rowspan="1" colspan="1">VCAM-1</td><td valign="top" align="left" rowspan="1" colspan="1">Migration<break/> Intercellular adhesion</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B75" ref-type="bibr">75</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x003b1;5&#x003b2;1</bold><break/>
<italic>VLA-5</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Fibronectin</td><td valign="top" align="left" rowspan="1" colspan="1">RGD Sequences</td><td valign="top" align="left" rowspan="1" colspan="1">Fibronectin receptor<break/> Migration</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B76" ref-type="bibr">76</xref>, <xref rid="B77" ref-type="bibr">77</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x003b1;6A&#x003b2;1</bold><break/>
<italic>VLA-6</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Laminin (not in macrophages, however)<break/> Fibronectin</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02013;</td><td valign="top" align="left" rowspan="1" colspan="1">Adhesion</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B78" ref-type="bibr">78</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003b2;3 Family</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x003b1;V&#x003b2;3</bold><break/>
<italic>CD51/CD63</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Vitronectin<break/> Fibrinogen</td><td valign="top" align="left" rowspan="1" colspan="1">VWF<break/> Thrombospondin<break/> RGD Sequences</td><td valign="top" align="left" rowspan="1" colspan="1">Vitronectin receptor<break/> Adhesion</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B77" ref-type="bibr">77</xref>, <xref rid="B79" ref-type="bibr">79</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><italic>&#x003b2;5 Family</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><bold>&#x003b1;V&#x003b2;5</bold></td><td valign="top" align="left" rowspan="1" colspan="1">Vitronectin<break/> (Fibrinogen and Fibronectin, minimally)</td><td valign="top" align="left" rowspan="1" colspan="1">MFG-E8</td><td valign="top" align="left" rowspan="1" colspan="1">Phagocytosis<break/> Debris clearance</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="B80" ref-type="bibr">80</xref>&#x02013;<xref rid="B82" ref-type="bibr">82</xref>)</td></tr></tbody></table><table-wrap-foot><p><italic>Integrin names are listed using &#x003b1; and &#x003b2; chain nomenclature with commonly used alternative names listed underneath</italic>.</p></table-wrap-foot></table-wrap></sec><sec><title>Effects of Integrin Activation on Macrophages</title><p>The &#x003b1;M&#x003b2;2 integrin (also commonly referred to as CD11b/CD18 and Mac-1, among others) is the most promiscuous integrin of the &#x003b2;2 integrin family. It is also the most studied of the integrins expressed by macrophages, however its impact on macrophage activation remains disputed. In <italic>Itgam</italic><sup>&#x02212;/&#x02212;</sup> (&#x003b1;M deficient) mice, tumor growth and immunosuppressive cytokine mRNA levels are enhanced relative to wild type mice, whereas constitutive activation of the &#x003b1;M integrin by a point mutation knock in (C57BL/6 ITGA-M <sup>I332G</sup>) inhibits tumor growth, despite increased IL-6 mRNA levels (<xref rid="B83" ref-type="bibr">83</xref>). In contrast, Han et al. argue that inflammatory cytokines are upregulated in <italic>Itgam</italic><sup>&#x02212;/&#x02212;</sup> mice (relative to <italic>Itgam</italic><sup>+/&#x02212;</sup> control mice) when challenged with TLR ligands (<xref rid="B84" ref-type="bibr">84</xref>). However, this increase is measured from serum and global knockout of &#x003b1;M likely impacts other immune cell types, such as dendritic and natural killer cells, which could contribute to this finding. &#x003b1;M&#x003b2;2 expression is upregulated in stiff, photo-induced cross-linked fibrin gels (<xref rid="B45" ref-type="bibr">45</xref>) and by the inflammatory stimuli LPS/ IFN-&#x003b3;. Its expression is also inhibited by TGF-&#x003b2;, a protein that is abundant in the TME and may contribute to tumor-directed immune suppression (<xref rid="B83" ref-type="bibr">83</xref>). On the other hand, work by the Xuetao Cao group has shown that TLR-mediated &#x003b1;M&#x003b2;2 activation, that leads to downstream Src and Syk activation, is capable of promoting alternative activation in murine macrophages via a IL-4-STAT6-Jak1 and MyD88-TRIF-Cbl-b mediated mechanism, respectively (<xref rid="B84" ref-type="bibr">84</xref>, <xref rid="B85" ref-type="bibr">85</xref>). Additionally, lysyl oxidase (LOX)-mediated collagen crosslinking within the primary and pre-metastatic TME aids in the retention of myeloid cells expressing the &#x003b1;M&#x003b2;2 integrin. The &#x003b1;M&#x003b2;2+ macrophages secrete MMPs to continue to reorganize the ECM, further contributing to increased macrophage levels in primary and metastatic breast tumors (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B86" ref-type="bibr">86</xref>, <xref rid="B87" ref-type="bibr">87</xref>).</p><p>In addition to &#x003b1;M&#x003b2;2, collagen specific adhesion receptors have also been shown to mediate macrophage activation. The importance of macrophage adhesion to collagen is underscored by the fact that the ECM in human primary breast cancers contains higher levels of collagen (I, III, IV, XIII) compared to normal breast tissue (<xref rid="B88" ref-type="bibr">88</xref>, <xref rid="B89" ref-type="bibr">89</xref>). The &#x003b1;2&#x003b2;1 integrin mediates macrophage migration and adhesion to type 1 collagen. A study by Cha et al. showed that &#x003b1;2&#x003b2;1, vinculin, PTK2, and the alternatively activated macrophage-associated marker CD206 are significantly upregulated by macrophages differentiated from THP-1 monocytes on hydrogels that allow for cell adhesion. Furthermore, this adhesion-mediated signaling augments the effects of IL-4 treatment. When &#x003b1;2&#x003b2;1 ligand binding is blocked with a neutralizing antibody, CD206 expression is significantly downregulated and cannot not be induced by the addition of IL-4, demonstrating that &#x003b1;2&#x003b2;1 engagement is important for alternative activation (<xref rid="B90" ref-type="bibr">90</xref>). Independent of soluble factors, it has also been shown that macrophages are able to sense mechanical deformations of the ECM from fibroblast contractions, and that these deformations alone are able to induce &#x003b1;2&#x003b2;1 mediated macrophage migration toward the fibroblasts (<xref rid="B91" ref-type="bibr">91</xref>). High numbers of cancer-associated fibroblasts are often observed in tumors, suggesting that cellular contractions from cancer-associated fibroblasts may dramatically deform the ECM to potentially aid the recruitment of &#x003b1;2&#x003b2;1-expressing TAMs locally. Moreover, scavenger receptor A (SR-A) and CD36 mediate macrophage adhesion to modified or denatured forms of type I and IV collagen, which are often found in inflammatory conditions (<xref rid="B92" ref-type="bibr">92</xref>&#x02013;<xref rid="B94" ref-type="bibr">94</xref>). CD36 is upregulated in alternatively activated macrophages (<xref rid="B95" ref-type="bibr">95</xref>), and SR-A is upregulated by macrophages when co-cultured with cancer cells (<xref rid="B96" ref-type="bibr">96</xref>). Interestingly, SR-A expressing TAMs colocalize in the stroma of tumors with FAP+ cancer associated fibroblasts that cleave collagen fibers to enhance TAM retention via SR-A mediated adhesion (<xref rid="B94" ref-type="bibr">94</xref>). SR-A-mediated macrophage adhesion plays an important role in cancer, as demonstrated by the prevention of ovarian cancer progression in mice treated with SR-A inhibitors (<xref rid="B96" ref-type="bibr">96</xref>, <xref rid="B97" ref-type="bibr">97</xref>).</p><p>Several other ECM protein ligands bind integrins expressed by macrophages. The &#x003b2;3 integrin is required for macrophage trans-endothelial migration on the ECM protein vitronectin. In human peripheral monocyte derived macrophages, ligand binding to &#x003b1;V&#x003b2;3 integrins activates a PI3-K/Akt signaling cascade resulting in NF-&#x003ba;B mediated gene expression and pro-inflammatory cytokine secretion. Interestingly, this pathway is synergistically enhanced by LPS/TNF-&#x003b1; stimulation (<xref rid="B98" ref-type="bibr">98</xref>). In contrast, in murine BMDMs &#x003b2;3 expression was seen to be significantly higher in M<sub>IL4+IL13</sub> macrophages compared to M<sub>LPS+IFN&#x003b3;</sub>, and its knockdown resulted in increased TNF-&#x003b1; secretion relative to the non-treated control (<xref rid="B45" ref-type="bibr">45</xref>). Additionally, the &#x003b2;4 laminin binding integrin is upregulated on the surface of TAMs in triple negative breast cancer. In combination with TGF-&#x003b2; signaling, ligand binding to &#x003b2;4 leads to increased integrin clustering and adhesion to lymphovasculature, which aids tumor cell dissemination (<xref rid="B99" ref-type="bibr">99</xref>).</p><p>Integrins are critical for cellular migration, and while macrophages are capable of utilizing both amoeboid and mesenchymal modes of migration, certain integrins may enhance macrophage migration in parallel with chemotactic signals. Macrophages can sense increases in fibronectin within the TME via the &#x003b1;5&#x003b2;1 integrin (<xref rid="B58" ref-type="bibr">58</xref>). &#x003b2;1 binding to fibronectin can couple with CSF1R, a master regulator of macrophage function and survival, on the plasma membrane leading to CSF1R-mediated phosphorylation via SFK/FAK (<xref rid="B100" ref-type="bibr">100</xref>). CSF1R has been strongly implicated in the recruitment and regulation of tumor promoting activities of TAMs (<xref rid="B101" ref-type="bibr">101</xref>), and is necessary for macrophage migration on fibronectin (<xref rid="B100" ref-type="bibr">100</xref>). Some have suggested that inflammatory signaling is required to prime integrins into the active state, allowing for increased ligand binding and signal transduction responsible for gene transcription, and interactions between adhesion and cytokine receptors lends strength to this argument (<xref rid="B58" ref-type="bibr">58</xref>).</p></sec></sec><sec id="s5"><title>Studying Macrophages <italic>in vivo</italic></title><sec><title>Challenges</title><p>Many challenges still exist when investigating macrophage biology, both <italic>in vitro</italic> and <italic>in vivo</italic>. The inconsistent findings from many of the studies discussed here can potentially be attributed to differences in cell lines, surface chemistries, time points analyzed, and other variables, but nonetheless emphasize the important fact that commonly used macrophage cell lines and primary cells exhibit differing responses to identical stimuli, often making <italic>in vitro</italic> findings difficult to compare. This is true for both murine (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B102" ref-type="bibr">102</xref>, <xref rid="B103" ref-type="bibr">103</xref>) and human (<xref rid="B104" ref-type="bibr">104</xref>, <xref rid="B105" ref-type="bibr">105</xref>) cell sources. Additionally, there are many differences between human and murine macrophage biology, from surface marker expression to metabolic states, that can result in stark differences in functional output (<xref rid="B106" ref-type="bibr">106</xref>&#x02013;<xref rid="B108" ref-type="bibr">108</xref>). Species specificity of macrophage cell types and the presence or absence of serum factors from humans vs. other species used in <italic>in vitro</italic> studies may also limit the applicability to human biology and therapeutic strategies. Thus, further studies are required to delineate murine and human macrophage responses, not only in mechanical studies.</p><p>Additional challenges exist when identifying the activation state of a macrophage, especially <italic>in vivo</italic>. Traditionally, phenotypes are identified using immunohistochemistry and transcriptional profiling, however these techniques require multiple markers to confirm an activation state and are most useful in <italic>in vitro</italic> or <italic>ex vivo</italic> studies at end stage time points. There is a great need for techniques to identify phenotypes through protein expression <italic>in vivo</italic>. While the use of genetically encoded fluorescent proteins to readout macrophage activation is possible, the use of multiple markers to confirm macrophage identity and the unintended effects of introducing exogenous proteins limits feasibility. Another area of concern, particularly in studies investigating mechanical regulation of macrophages is the fact that macrophages respond differently to substrates in 2-D compared to 3-D. Currently, most studies are performed using 2-D methods to investigate migration and activation. There is a great need for more studies investigating macrophages in 3-D, especially in the context of cancer, as it is more representative of the environment macrophages naturally reside in. It is imperative to improve methods of investigating macrophages in their native environments so as to minimize variances that arise from culture and experimental conditions, and to best elucidate the impact of the ECM on macrophages.</p></sec><sec><title>Current Approaches</title><p>In order to observe macrophages in the tumor microenvironment, the field has recently turned to optical approaches such as positron emission tomography (PET), for example [reviewed extensively in (<xref rid="B109" ref-type="bibr">109</xref>)]. Rostam et al. have proposed image-based machine learning to identify phenotypes based on cellular morphology which, as described earlier, may provide some indication of phenotype (<xref rid="B110" ref-type="bibr">110</xref>). The availability of 3-D culture platforms to investigate macrophage&#x02013;tumor cell interactions provide a tool kit to identify macrophage phenotype in more <italic>in vivo</italic>-like microenvironments (<xref rid="B111" ref-type="bibr">111</xref>&#x02013;<xref rid="B113" ref-type="bibr">113</xref>). Using these platforms, one can take advantage of pharmacologic and optogenetic approaches to manipulate adhesion receptor activation and downstream signaling pathways involved in macrophage responses to biophysical cues from the ECM (<xref rid="B114" ref-type="bibr">114</xref>&#x02013;<xref rid="B116" ref-type="bibr">116</xref>).</p><p>In addition to PET and single-photon emission computed tomography (SPECT) (<xref rid="B109" ref-type="bibr">109</xref>), another technique, intravital imaging, utilizes small implanted imaging windows paired with confocal or multiphoton microscopy to visualize the spatial organization of tumor and stromal cell populations (<xref rid="B117" ref-type="bibr">117</xref>, <xref rid="B118" ref-type="bibr">118</xref>). Cell-type-specific expression of proteins that are genetically fused with fluorescent tags, such as GFP or mCherry, as well as the endogenously fluorescent metabolic cofactors FAD<sup>+</sup> and NADH (<xref rid="B119" ref-type="bibr">119</xref>) can be used to identify macrophage, tumor, and other cell types in the mouse (<xref ref-type="fig" rid="F2">Figure 2</xref>). This technique has facilitated direct observation of macrophages interacting with and assisting tumor cells to intravasate into nearby vasculature, as well as tumor cell extravasation at distant metastatic sites (<xref rid="B121" ref-type="bibr">121</xref>, <xref rid="B122" ref-type="bibr">122</xref>). While this approach provides detailed spatial and temporal resolution of cells in the TME, there is still a lack of validated signatures to fully identify and characterize macrophage phenotypes <italic>in vivo</italic>. One emerging signature of macrophage activation is the use of fluorescence lifetime. Fluorescence Lifetime Imaging Microscopy (FLIM) reports the time a fluorophore remains in the excited state before transitioning back to ground state, and differences in fluorescent lifetimes of NADH and FAD<sup>+</sup> can indicate whether the cofactors are free or protein bound. Changes in the relative concentrations of bound vs. free NADH and FAD<sup>+</sup> can provide information on metabolic states at the single cell level (<xref rid="B123" ref-type="bibr">123</xref>, <xref rid="B124" ref-type="bibr">124</xref>). Within the TME, Szulczewski et al. demonstrated that stromal macrophages have a distinct NADH FLIM signature, allowing them to be distinguished from tumor cells (<xref rid="B119" ref-type="bibr">119</xref>). Along these lines, Alfonso-Garcia et al. show stark differences in the NADH fluorescence lifetime signatures in M<sub>LPS+IFN&#x003b3;</sub> and M<sub>IL4+IL13</sub> induced BMDMs <italic>in vitro</italic> (<xref rid="B125" ref-type="bibr">125</xref>), thus warranting further investigation into the use of FLIM to identify macrophage activation <italic>in vitro</italic> and <italic>in vivo</italic>. In addition to endogenous and genetically expressed fluorescence, ported mammary imaging windows that feature a needle inserted through the window base have been used to inject fluorescently conjugated antibodies. This methodology provides an opportunity for real-time visualization of the localization and relative abundance of cell type specific proteins, such as macrophage activation markers and integrins.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Intravital imaging of mammary carcinoma in a MMTV-PyMT mouse. 2-photon scanning laser microscopy allows for the <italic>in vivo</italic> observation of tumor cells (high in NADH intensity, 780 nm excitation), collagen fibers through second harmonic generation (890 nm excitation), and <bold>(A)</bold> Macrophages expressing the fluorescent mCherry protein under the CSF1-R promotor (C57BL/6-Tg(Csf1r-HBEGF/mCherry)1Mnz/J X B6.129P2-Lyz2<sup>tm1(cre)Ifo</sup>/J) (<xref rid="B120" ref-type="bibr">120</xref>) (1050nm excitation). <bold>(B)</bold> FAD<sup>HI</sup> cells which depict primarily macrophage stromal cells (<xref rid="B119" ref-type="bibr">119</xref>). <bold>(C)</bold> NADH fluorescence lifetime overlay on mask of mCherry+ cells (color map of NADH &#x003c4;m lifetime). <bold>(D)</bold> Insets depict mcherry<sup>+</sup> macrophages, which are FAD bright, spatially localized in the collagen rich stroma or within the tumor mass. Arrow indicates a macrophage spread in a collagen abundant region of the tumor stroma. Dashed outline depicts a macrophage elongated in an aligned region of collagen fibers at the boundary of a tumor nest.</p></caption><graphic xlink:href="fonc-10-00787-g0002"/></fig></sec></sec><sec sec-type="conclusions" id="s6"><title>Conclusion</title><p>Taming tumor-associated macrophages has been a long-time goal for cancer therapy, and much work remains to fully understand the crosstalk between macrophages and the tumor microenvironment. While a causal mechanistic link between biomechanical properties of the ECM and macrophage activation has yet to be fully established <italic>in vivo</italic>, here we highlight studies that investigate the relationship and crosstalk between biophysical properties of the ECM and macrophage activation. Further investigation into downstream signaling pathways activated by integrin ligand binding and mechanical stimuli is necessary to identify potential therapeutic interventions to shift TAMs away from a tumor promoting phenotype. One expanding area is the use of metabolic reprogramming to shift macrophage phenotypes. Classically and alternatively activated macrophages favor differing metabolic mechanisms, and differences in the fluorescence lifetime signatures of metabolic cofactors lends support to the use of metabolism as a phenotypic marker. Moreover, integrin activation through the &#x003b1;2&#x003b2;1 integrin can induce activation the PI3K-Akt pathway (<xref rid="B126" ref-type="bibr">126</xref>), and macrophage metabolism is strongly regulated by PI3k-Akt-mTOR signaling which can prime macrophages toward either activation state depending on confounding biochemical stimuli in the TME such as hypoxia or IL-4 (<xref rid="B127" ref-type="bibr">127</xref>). Metabolism provides an attractive target for manipulation, as it is highly sensitive and fast responding to changes inside and outside the cell, critical characteristics for macrophages to alter their activation in an inducible and reversible manner.</p></sec><sec id="s7"><title>Author Contributions</title><p>EH wrote the first draft of the manuscript. All authors contributed to manuscript and figure conceptualization and design, revision, read and approved the submitted version.</p></sec><sec id="s8"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>The authors would like to acknowledge the help of David R. Inman for his assistance in the setup and collection of the intravital images which contributed to <xref ref-type="fig" rid="F2">Figure 2</xref>. <xref ref-type="fig" rid="F1">Figure 1</xref> was created with <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">Biorender.com</ext-link>.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by the National Institutes of Health (RO1 CA142833, RO1 CA216248, and RO1 CA2026458). EH was supported by T32 GM008688.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingman</surname><given-names>WV</given-names></name><name><surname>Wyckoff</surname><given-names>J</given-names></name><name><surname>Gouon-Evans</surname><given-names>V</given-names></name><name><surname>Condeelis</surname><given-names>J</given-names></name><name><surname>Pollard</surname><given-names>JW</given-names></name></person-group>. <article-title>Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland</article-title>. <source>Dev Dyn</source>. (<year>2006</year>) <volume>235</volume>:<fpage>3222</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.20972</pub-id><?supplied-pmid 17029292?><pub-id pub-id-type="pmid">17029292</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Movahedi</surname><given-names>K</given-names></name><name><surname>Van Ginderachter</surname><given-names>JA</given-names></name></person-group>. <article-title>The ontogeny and microenvironmental regulation of tumor-associated macrophages</article-title>. <source>Antioxid Redox Signal</source>. (<year>2016</year>) <volume>25</volume>:<fpage>775</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2016.6704</pub-id><?supplied-pmid 27020982?><pub-id pub-id-type="pmid">27020982</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>TD</given-names></name><name><surname>Tse</surname><given-names>MJ</given-names></name><name><surname>Read</surname><given-names>EL</given-names></name><name><surname>Liu</surname><given-names>WF</given-names></name></person-group>. <article-title>Regulation of macrophage polarization and plasticity by complex activation signals</article-title>. <source>Integr Biol.</source> (<year>2016</year>) <volume>8</volume>:<fpage>946</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1039/c6ib00105j</pub-id><?supplied-pmid 27492191?><pub-id pub-id-type="pmid">27492191</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gundra</surname><given-names>UM</given-names></name><name><surname>Girgis</surname><given-names>NM</given-names></name><name><surname>Ruckerl</surname><given-names>D</given-names></name><name><surname>Jenkins</surname><given-names>S</given-names></name><name><surname>Ward</surname><given-names>LN</given-names></name><name><surname>Kurtz</surname><given-names>ZD</given-names></name><etal/></person-group>. <article-title>Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct</article-title>. <source>Blood.</source> (<year>2014</year>) <volume>123</volume>:<fpage>e110</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2013-08-520619</pub-id><?supplied-pmid 24695852?><pub-id pub-id-type="pmid">24695852</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chittezhath</surname><given-names>M</given-names></name><name><surname>Dhillon</surname><given-names>MK</given-names></name><name><surname>Lim</surname><given-names>JY</given-names></name><name><surname>Laoui</surname><given-names>D</given-names></name><name><surname>Shalova</surname><given-names>IN</given-names></name><name><surname>Teo</surname><given-names>YL</given-names></name><etal/></person-group>. <article-title>Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression</article-title>. <source>Immunity</source>. (<year>2014</year>) <volume>41</volume>:<fpage>815</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2014.09.014</pub-id><?supplied-pmid 25453823?><pub-id pub-id-type="pmid">25453823</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>SV</given-names></name><name><surname>Sander</surname><given-names>J</given-names></name><name><surname>Draffehn</surname><given-names>A</given-names></name><name><surname>Krebs</surname><given-names>W</given-names></name><name><surname>Quester</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>Transcriptome-based network analysis reveals a spectrum model of human macrophage activation</article-title>. <source>Immunity</source>. (<year>2014</year>) <volume>40</volume>:<fpage>274</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2014.01.006</pub-id><?supplied-pmid 24530056?><pub-id pub-id-type="pmid">24530056</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>PJ</given-names></name><name><surname>Allen</surname><given-names>JE</given-names></name><name><surname>Biswas</surname><given-names>SK</given-names></name><name><surname>Fisher</surname><given-names>EA</given-names></name><name><surname>Gilroy</surname><given-names>DW</given-names></name><name><surname>Goerdt</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Macrophage activation and polarization: nomenclature and experimental guidelines</article-title>. <source>Immunity.</source> (<year>2014</year>) <volume>41</volume>:<fpage>14</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.008</pub-id><?supplied-pmid 25035950?><pub-id pub-id-type="pmid">25035950</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneemann</surname><given-names>M</given-names></name><name><surname>Schoeden</surname><given-names>G</given-names></name></person-group>
<article-title>Macrophage biology and immunology: man is not a mouse</article-title>. <source>J Leukoc Biol</source>. (<year>2007</year>) <volume>81</volume>:<fpage>579</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.1106702</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>TJ</given-names></name><name><surname>Kremens</surname><given-names>K</given-names></name><name><surname>Powers</surname><given-names>LS</given-names></name><name><surname>Brink</surname><given-names>B</given-names></name><name><surname>Knutson</surname><given-names>T</given-names></name><name><surname>Domann</surname><given-names>FE</given-names></name><etal/></person-group>. <article-title>Epigenetic silencing of the human NOS2 gene: rethinking the role of nitric oxide in human macrophage inflammatory responses</article-title>. <source>J Immunol</source>. (<year>2014</year>) <volume>192</volume>:<fpage>2326</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1301758</pub-id><?supplied-pmid 24477906?><pub-id pub-id-type="pmid">24477906</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynn</surname><given-names>TA</given-names></name><name><surname>Chawla</surname><given-names>A</given-names></name><name><surname>Pollard</surname><given-names>JW</given-names></name></person-group>. <article-title>Macrophage biology in development, homeostasis and disease</article-title>. <source>Nature</source>. (<year>2013</year>) <volume>496</volume>:<fpage>445</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1038/nature12034</pub-id><?supplied-pmid 23619691?><pub-id pub-id-type="pmid">23619691</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bingle</surname><given-names>L</given-names></name><name><surname>Brown</surname><given-names>NJ</given-names></name><name><surname>Lewis</surname><given-names>CE</given-names></name></person-group>. <article-title>The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies</article-title>. <source>J Pathol</source>. (<year>2002</year>) <volume>196</volume>:<fpage>254</fpage>&#x02013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1002/path.1027</pub-id><?supplied-pmid 11857487?><pub-id pub-id-type="pmid">11857487</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>QW</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Gong</surname><given-names>CY</given-names></name><name><surname>Shi</surname><given-names>HS</given-names></name><name><surname>Zeng</surname><given-names>YH</given-names></name><name><surname>Wang</surname><given-names>XZ</given-names></name><etal/></person-group>. <article-title>Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature</article-title>. <source>PLoS ONE</source>. (<year>2012</year>) <volume>7</volume>:<fpage>e50946</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0050946</pub-id><?supplied-pmid 23284651?><pub-id pub-id-type="pmid">23284651</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Lan</surname><given-names>H</given-names></name></person-group>. <article-title>Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications</article-title>. <source>J Hematol Oncol</source>. (<year>2019</year>) <volume>12</volume>:<fpage>76</fpage>. <pub-id pub-id-type="doi">10.1186/s13045-019-0760-3</pub-id><?supplied-pmid 31300030?><pub-id pub-id-type="pmid">31300030</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>NB</given-names></name><name><surname>L&#x000fc;</surname><given-names>MH</given-names></name><name><surname>Fan</surname><given-names>YH</given-names></name><name><surname>Cao</surname><given-names>YL</given-names></name><name><surname>Zhang</surname><given-names>ZR</given-names></name><name><surname>Yang</surname><given-names>SM</given-names></name></person-group>. <article-title>Macrophages in tumor microenvironments and the progression of tumors</article-title>. <source>Clin Dev Immunol</source>. (<year>2012</year>) <volume>2012</volume>:<fpage>948098</fpage>. <pub-id pub-id-type="doi">10.1155/2012/948098</pub-id><?supplied-pmid 22778768?><pub-id pub-id-type="pmid">22778768</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flier</surname><given-names>JS</given-names></name><name><surname>Underhill</surname><given-names>LH</given-names></name><name><surname>Dvorak</surname><given-names>HF</given-names></name></person-group>
<article-title>Tumors: wounds that do not heal</article-title>. <source>N Engl J Med</source>. (<year>1986</year>) <volume>315</volume>:<fpage>1650</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM198612253152606</pub-id><pub-id pub-id-type="pmid">3537791</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>C</given-names></name><name><surname>Mojares</surname><given-names>E</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>AD</given-names></name></person-group>. <article-title>Role of extracellular matrix in development and cancer progression</article-title>. <source>Int J Mol Sci</source>. (<year>2018</year>) <volume>19</volume>:<fpage>3028</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19103028</pub-id><?supplied-pmid 30287763?><pub-id pub-id-type="pmid">30287763</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lochter</surname><given-names>A</given-names></name><name><surname>Bissell</surname><given-names>MJ</given-names></name></person-group>. <article-title>Involvement of extracellular matrix constituents in breast cancer</article-title>. <source>Semin Cancer Biol</source>. (<year>1995</year>) <volume>6</volume>:<fpage>165</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1006/scbi.1995.0017</pub-id><?supplied-pmid 7495985?><pub-id pub-id-type="pmid">7495985</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conklin</surname><given-names>MW</given-names></name><name><surname>Eickhoff</surname><given-names>JC</given-names></name><name><surname>Riching</surname><given-names>KM</given-names></name><name><surname>Pehlke</surname><given-names>CA</given-names></name><name><surname>Eliceiri</surname><given-names>KW</given-names></name><name><surname>Provenzano</surname><given-names>PP</given-names></name><etal/></person-group>. <article-title>Aligned collagen is a prognostic signature for survival in human breast carcinoma</article-title>. <source>Am J Pathol</source>. (<year>2011</year>) <volume>178</volume>:<fpage>1221</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2010.11.076</pub-id><?supplied-pmid 21356373?><pub-id pub-id-type="pmid">21356373</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>NF</given-names></name><name><surname>Lockwood</surname><given-names>GA</given-names></name><name><surname>Byng</surname><given-names>JW</given-names></name><name><surname>Tritchler</surname><given-names>DL</given-names></name><name><surname>Yaffe</surname><given-names>MJ</given-names></name></person-group>. <article-title>Mammographic densities and breast cancer risk</article-title>. <source>Cancer Epidemiol Biomark Preven</source>. (<year>1998</year>) <volume>7</volume>:<fpage>1133</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.3233/BD-1998-103-412</pub-id><?supplied-pmid 9865433?><pub-id pub-id-type="pmid">9865433</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>NF</given-names></name><name><surname>Guo</surname><given-names>H</given-names></name><name><surname>Martin</surname><given-names>LJ</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Stone</surname><given-names>J</given-names></name><name><surname>Fishell</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Mammographic density and the risk and detection of breast cancer</article-title>. <source>N Engl J Med</source>. (<year>2007</year>) <volume>356</volume>:<fpage>227</fpage>&#x02013;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa062790</pub-id><?supplied-pmid 17229950?><pub-id pub-id-type="pmid">17229950</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alowami</surname><given-names>S</given-names></name><name><surname>Troup</surname><given-names>S</given-names></name><name><surname>Al-Haddad</surname><given-names>S</given-names></name><name><surname>Kirkpatrick</surname><given-names>I</given-names></name><name><surname>Watson</surname><given-names>PH</given-names></name></person-group>. <article-title>Mammographic density is related to stroma and stromal proteoglycan expression</article-title>. <source>Br Cancer Res</source>. (<year>2003</year>) <volume>5</volume>:<fpage>129</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1186/bcr622</pub-id><?supplied-pmid 12927043?><pub-id pub-id-type="pmid">12927043</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mcconnell</surname><given-names>JC</given-names></name><name><surname>O'Connell</surname><given-names>OV</given-names></name><name><surname>Brennan</surname><given-names>K</given-names></name><name><surname>Weiping</surname><given-names>L</given-names></name><name><surname>Howe</surname><given-names>M</given-names></name><name><surname>Joseph</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Increased peri-ductal collagen micro- organization may contribute to raised mammographic density</article-title>. <source>Br Cancer Res</source>. (<year>2016</year>) <volume>18</volume>:<fpage>5</fpage>. <pub-id pub-id-type="doi">10.1186/s13058-015-0664-2</pub-id><?supplied-pmid 26747277?><pub-id pub-id-type="pmid">26747277</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acerbi</surname><given-names>I</given-names></name><name><surname>Cassereau</surname><given-names>L</given-names></name><name><surname>Dean</surname><given-names>I</given-names></name><name><surname>Shi</surname><given-names>Q</given-names></name><name><surname>Au</surname><given-names>A</given-names></name><name><surname>Park</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration</article-title>. <source>Integr Biol</source>. (<year>2015</year>) <volume>7</volume>:<fpage>1120</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1039/c5ib00040h</pub-id><?supplied-pmid 25959051?><pub-id pub-id-type="pmid">25959051</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huo</surname><given-names>CW</given-names></name><name><surname>Hill</surname><given-names>P</given-names></name><name><surname>Chew</surname><given-names>G</given-names></name><name><surname>Neeson</surname><given-names>PJ</given-names></name><name><surname>Halse</surname><given-names>H</given-names></name><name><surname>Williams</surname><given-names>ED</given-names></name><etal/></person-group>. <article-title>High Mammographic Density in Women Is Associated with Protumor Inflammation</article-title>. <source>Br Cancer Res</source>. (<year>2018</year>) <volume>20</volume>:<fpage>1</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1186/s13058-018-1010-2</pub-id><?supplied-pmid 30092832?><pub-id pub-id-type="pmid">30092832</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Provenzano</surname><given-names>PP</given-names></name><name><surname>Eliceiri</surname><given-names>KW</given-names></name><name><surname>Campbell</surname><given-names>JM</given-names></name><name><surname>Inman</surname><given-names>DR</given-names></name><name><surname>White</surname><given-names>JG</given-names></name><name><surname>Keely</surname><given-names>PJ</given-names></name></person-group>. <article-title>Collagen reorganization at the tumor-stromal interface facilitates local invasion</article-title>. <source>BMC Med</source>. (<year>2006</year>) <volume>4</volume>:<fpage>38</fpage>. <pub-id pub-id-type="doi">10.1186/1741-7015-4-38</pub-id><?supplied-pmid 17190588?><pub-id pub-id-type="pmid">17190588</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esbona</surname><given-names>K</given-names></name><name><surname>Yi</surname><given-names>Y</given-names></name><name><surname>Saha</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Van Doorn</surname><given-names>RR</given-names></name><name><surname>Conklin</surname><given-names>MW</given-names></name><etal/></person-group>. <article-title>The presence of cyclooxygenase 2, tumor-associated macrophages, and collagen alignment as prognostic markers for invasive breast carcinoma patients</article-title>. <source>Am J Pathol</source>. (<year>2018</year>) <volume>188</volume>:<fpage>616</fpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2017.10.025</pub-id><?supplied-pmid 29429545?><pub-id pub-id-type="pmid">29248457</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessenbrock</surname><given-names>K</given-names></name><name><surname>Plaks</surname><given-names>V</given-names></name><name><surname>Werb</surname><given-names>Z</given-names></name></person-group>. <article-title>Matrix metalloproteinases: regulators of the tumor microenvironment</article-title>. <source>Cell</source>. (<year>2010</year>) <volume>141</volume>:<fpage>52</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.03.015</pub-id><?supplied-pmid 20371345?><pub-id pub-id-type="pmid">20371345</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afik</surname><given-names>R</given-names></name><name><surname>Zigmond</surname><given-names>E</given-names></name><name><surname>Vugman</surname><given-names>M</given-names></name><name><surname>Klepfish</surname><given-names>M</given-names></name><name><surname>Shimshoni</surname><given-names>E</given-names></name><name><surname>Pasmanik-Chor</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Tumor macrophages are pivotal constructors of tumor collagenous matrix</article-title>. <source>J Exp Med</source>. (<year>2016</year>) <volume>213</volume>:<fpage>2315</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20151193</pub-id><?supplied-pmid 27697834?><pub-id pub-id-type="pmid">27697834</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varol</surname><given-names>C</given-names></name></person-group>. <article-title>Tumorigenic interplay between macrophages and collagenous matrix in the tumor microenvironment</article-title>. <source>Methods Mol Biol</source>. (<year>2019</year>) <volume>1944</volume>:<fpage>203</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-9095-5_15</pub-id><?supplied-pmid 30840245?><pub-id pub-id-type="pmid">30840245</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YL</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Liang</surname><given-names>JW</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Hu</surname><given-names>BQ</given-names></name><etal/></person-group>. <article-title>High plasma fibrinogen is correlated with poor response to trastuzumab treatment in HER2 positive breast cancer</article-title>. <source>Medicine.</source> (<year>2015</year>) <volume>94</volume>:<fpage>e481</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000000481</pub-id><?supplied-pmid 25654390?><pub-id pub-id-type="pmid">25654390</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>YK</given-names></name><name><surname>Kim</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>MK</given-names></name><name><surname>Choi</surname><given-names>JE</given-names></name><name><surname>Kang</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name></person-group>. <article-title>Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer</article-title>. <source>Human Pathol</source>. (<year>2013</year>) <volume>44</volume>:<fpage>2028</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1016/j.humpath.2013.03.006</pub-id><?supplied-pmid 23684510?><pub-id pub-id-type="pmid">23684510</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>JY</given-names></name><name><surname>Smith</surname><given-names>TD</given-names></name><name><surname>Meli</surname><given-names>VS</given-names></name><name><surname>Tran</surname><given-names>TN</given-names></name><name><surname>Botvinick</surname><given-names>EL</given-names></name><name><surname>Liu</surname><given-names>WF</given-names></name></person-group>. <article-title>Differential regulation of macrophage inflammatory activation by fibrin and fibrinogen</article-title>. <source>Acta Biomater.</source> (<year>2017</year>) <volume>47</volume>:<fpage>14</fpage>&#x02013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2016.09.024</pub-id><?supplied-pmid 27662809?><pub-id pub-id-type="pmid">27662809</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudhakaran</surname><given-names>PR</given-names></name><name><surname>Radhika</surname><given-names>A</given-names></name><name><surname>Jacob</surname><given-names>SS</given-names></name></person-group>. <article-title>Monocyte macrophage differentiation <italic>in vitro</italic>: fibronectin-dependent upregulation of certain macrophage-specific activities</article-title>. <source>Glycoconjugate J</source>. (<year>2007</year>) <volume>24</volume>:<fpage>49</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1007/s10719-006-9011-2</pub-id><?supplied-pmid 17115276?><pub-id pub-id-type="pmid">17115276</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosesson</surname><given-names>MW</given-names></name></person-group>. <article-title>The role of fibronectin in monocyte/macrophage function</article-title>. <source>Progr Clin Biol Res</source>. (<year>1984</year>) <volume>154</volume>:<fpage>155</fpage>&#x02013;<lpage>75</lpage>. <?supplied-pmid 6089231?><pub-id pub-id-type="pmid">6089231</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Givant-Horwitz</surname><given-names>V</given-names></name><name><surname>Davidson</surname><given-names>B</given-names></name><name><surname>Reich</surname><given-names>R</given-names></name></person-group>. <article-title>Laminin-Induced Signaling in Tumor Cells</article-title>. <source>Cancer Lett</source>. (<year>2005</year>) <volume>223</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2004.08.030</pub-id><?supplied-pmid 15890231?><pub-id pub-id-type="pmid">15890231</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rick</surname><given-names>JW</given-names></name><name><surname>Chandra</surname><given-names>A</given-names></name><name><surname>Ore</surname><given-names>CD</given-names></name><name><surname>Nguyen</surname><given-names>AT</given-names></name><name><surname>Yagnik</surname><given-names>G</given-names></name><name><surname>Aghi</surname><given-names>MK</given-names></name></person-group>. <article-title>Fibronectin in malignancy: cancer-specific alterations, protumoral effects, and therapeutic implications</article-title>. <source>Semin Oncol</source>. (<year>2019</year>) <volume>46</volume>:<fpage>284</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1053/j.seminoncol.2019.08.002</pub-id><?supplied-pmid 31488338?><pub-id pub-id-type="pmid">31488338</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Provenzano</surname><given-names>PP</given-names></name><name><surname>Inman</surname><given-names>DR</given-names></name><name><surname>Eliceiri</surname><given-names>KW</given-names></name><name><surname>Knittel</surname><given-names>JG</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Rueden</surname><given-names>CT</given-names></name><etal/></person-group>. <article-title>Collagen density promotes mammary tumor initiation and progression</article-title>. <source>BMC Med</source>. (<year>2008</year>) <volume>6</volume>:<fpage>11</fpage>. <pub-id pub-id-type="doi">10.1186/1741-7015-6-11</pub-id><?supplied-pmid 18442412?><pub-id pub-id-type="pmid">18442412</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esbona</surname><given-names>K</given-names></name><name><surname>Inman</surname><given-names>D</given-names></name><name><surname>Saha</surname><given-names>S</given-names></name><name><surname>Jeffery</surname><given-names>J</given-names></name><name><surname>Schedin</surname><given-names>P</given-names></name><name><surname>Wilke</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>COX-2 modulates mammary tumor progression in response to collagen density</article-title>. <source>Br Cancer Res.</source> (<year>2016</year>) <volume>18</volume>:<fpage>35</fpage>. <pub-id pub-id-type="doi">10.1186/s13058-016-0695-3</pub-id><?supplied-pmid 27000374?><pub-id pub-id-type="pmid">27000374</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linde</surname><given-names>N</given-names></name><name><surname>Casanova-Acebes</surname><given-names>M</given-names></name><name><surname>Sosa</surname><given-names>MS</given-names></name><name><surname>Mortha</surname><given-names>A</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Farias</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Macrophages orchestrate breast cancer early dissemination and metastasis</article-title>. <source>Nat Commun</source>. (<year>2018</year>) <volume>9</volume>:<fpage>21</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-02481-5</pub-id><?supplied-pmid 29295986?><pub-id pub-id-type="pmid">29295986</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>E</given-names></name><name><surname>Xue</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Rougerie</surname><given-names>P</given-names></name><name><surname>Sharma</surname><given-names>VP</given-names></name><name><surname>Eddy</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Blood vessel endothelium-directed tumor cell streaming in breast tumors requires the HGF/C-met signaling pathway</article-title>. <source>Oncogene</source>. (<year>2017</year>) <volume>36</volume>:<fpage>2680</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2016.421</pub-id><?supplied-pmid 27893712?><pub-id pub-id-type="pmid">27893712</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arwert</surname><given-names>EN</given-names></name><name><surname>Harney</surname><given-names>AS</given-names></name><name><surname>Entenberg</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Sahai</surname><given-names>E</given-names></name><name><surname>Pollard</surname><given-names>JW</given-names></name><etal/></person-group>
<article-title>A unidirectional transition from migratory to perivascular macrophage is required for tumor cell intravasation</article-title>. <source>Cell Rep</source>. (<year>2018</year>) <volume>17</volume>:<fpage>2445</fpage>&#x02013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.04.007</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotchkiss</surname><given-names>KM</given-names></name><name><surname>Reddy</surname><given-names>GB</given-names></name><name><surname>Hyzy</surname><given-names>SL</given-names></name><name><surname>Schwartz</surname><given-names>Z</given-names></name><name><surname>Boyan</surname><given-names>BD</given-names></name><name><surname>Olivares-Navarrete</surname><given-names>R</given-names></name></person-group>. <article-title>Titanium surface characteristics, including topography and wettability, alter macrophage activation</article-title>. <source>Acta Biomater.</source> (<year>2016</year>) <volume>31</volume>:<fpage>425</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2015.12.003</pub-id><?supplied-pmid 26675126?><pub-id pub-id-type="pmid">26675126</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Refai</surname><given-names>AK</given-names></name><name><surname>Textor</surname><given-names>M</given-names></name><name><surname>Brunette</surname><given-names>DM</given-names></name><name><surname>Waterfield</surname><given-names>JD</given-names></name></person-group>. <article-title>Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines</article-title>. <source>J Biomed Mater Res Part A</source>. (<year>2004</year>) <volume>70</volume>:<fpage>194</fpage>&#x02013;<lpage>205</lpage>. <pub-id pub-id-type="doi">10.1002/jbm.a.30075</pub-id><?supplied-pmid 15227664?><pub-id pub-id-type="pmid">15227664</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>KS</given-names></name><name><surname>Qian</surname><given-names>L</given-names></name><name><surname>Rosado</surname><given-names>R</given-names></name><name><surname>Flood</surname><given-names>PM</given-names></name><name><surname>Cooper</surname><given-names>LF</given-names></name></person-group>. <article-title>The role of titanium surface topography on J774A.1 macrophage inflammatory cytokines and nitric oxide production</article-title>. <source>Biomaterials.</source> (<year>2006</year>) <volume>27</volume>:<fpage>5170</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2006.05.002</pub-id><?supplied-pmid 16808973?><pub-id pub-id-type="pmid">16808973</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>JY</given-names></name><name><surname>Keating</surname><given-names>MT</given-names></name><name><surname>Smith</surname><given-names>TD</given-names></name><name><surname>Meli</surname><given-names>VS</given-names></name><name><surname>Botvinick</surname><given-names>EL</given-names></name><name><surname>Wendy Liu</surname><given-names>WF</given-names></name></person-group>. <article-title>Matrix crosslinking enhances macrophage adhesion, migration, and inflammatory activation</article-title>. <source>APL Bioengineering</source>. (<year>2019</year>) <volume>3</volume>:<fpage>016103</fpage>. <pub-id pub-id-type="doi">10.1063/1.5067301</pub-id><?supplied-pmid 31069336?><pub-id pub-id-type="pmid">31069336</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Previtera</surname><given-names>ML</given-names></name><name><surname>Sengupta</surname><given-names>A</given-names></name></person-group>. <article-title>Substrate stiffness regulates proinflammatory mediator production through TLR4 activity in macrophages</article-title>. <source>PLoS ONE.</source> (<year>2015</year>) <volume>10</volume>:<fpage>145813</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0145813</pub-id><?supplied-pmid 26710072?><pub-id pub-id-type="pmid">26710072</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Edwards</surname><given-names>JP</given-names></name><name><surname>Mosser</surname><given-names>DM</given-names></name></person-group>. <article-title>NF-KappaB1. (P50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages</article-title>. <source>J Biol Chem</source>. (<year>2006</year>) <volume>281</volume>:<fpage>26041</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M602222200</pub-id><?supplied-pmid 16835236?><pub-id pub-id-type="pmid">16835236</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McWhorter</surname><given-names>FY</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Nguyen</surname><given-names>P</given-names></name><name><surname>Chung</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>WF</given-names></name></person-group>. <article-title>Modulation of macrophage phenotype by cell shape</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2013</year>) <volume>110</volume>:<fpage>17253</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1308887110</pub-id><?supplied-pmid 24101477?><pub-id pub-id-type="pmid">24101477</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>N</given-names></name><name><surname>Vogel</surname><given-names>V</given-names></name></person-group>. <article-title>Spatial confinement downsizes the inflammatory response of macrophages</article-title>. <source>Nat Mater</source>. (<year>2018</year>) <volume>17</volume>:<fpage>1134</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1038/s41563-018-0190-6</pub-id><?supplied-pmid 30349032?><pub-id pub-id-type="pmid">30349032</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luu</surname><given-names>TU</given-names></name><name><surname>Gott</surname><given-names>SC</given-names></name><name><surname>Woo</surname><given-names>BWK</given-names></name><name><surname>Rao</surname><given-names>MP</given-names></name><name><surname>Liu</surname><given-names>WF</given-names></name></person-group>. <article-title>Micro- and nanopatterned topographical cues for regulating macrophage cell shape and phenotype</article-title>. <source>ACS Appl Mater Interf</source>. (<year>2015</year>) <volume>7</volume>:<fpage>28665</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.5b10589</pub-id><?supplied-pmid 26605491?><pub-id pub-id-type="pmid">26605491</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>W&#x000f3;jciak-Stothard</surname><given-names>B</given-names></name><name><surname>Curtis</surname><given-names>A</given-names></name><name><surname>Monaghan</surname><given-names>W</given-names></name><name><surname>Macdonald</surname><given-names>K</given-names></name><name><surname>Wilkinson</surname><given-names>C</given-names></name></person-group>. <article-title>Guidance and activation of murine macrophages by nanometric scale topography</article-title>. <source>Exp Cell Res</source>. (<year>1996</year>) <volume>223</volume>:<fpage>426</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1006/excr.1996.0098</pub-id><?supplied-pmid 8601420?><pub-id pub-id-type="pmid">8601420</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giancotti</surname><given-names>FG</given-names></name><name><surname>Ruoslahti</surname><given-names>E</given-names></name></person-group>. <article-title>Integrin signaling</article-title>. <source>Science</source>. (<year>1999</year>) <volume>285</volume>:<fpage>1028</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1126/science.285.5430.1028</pub-id><?supplied-pmid 10446041?><pub-id pub-id-type="pmid">10446041</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostermann</surname><given-names>G</given-names></name><name><surname>Weber</surname><given-names>KSC</given-names></name><name><surname>Zernecke</surname><given-names>A</given-names></name><name><surname>Schr&#x000f6;der</surname><given-names>A</given-names></name><name><surname>Weber</surname><given-names>C</given-names></name></person-group>
<article-title>JAM-I is a ligand of the B2 integrin LFA-I involved in transendothelial migration of leukocytes</article-title>. <source>Nat Immunol</source>. (<year>2002</year>) <volume>3</volume>:<fpage>151</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/ni755</pub-id><pub-id pub-id-type="pmid">11812992</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Kilgannon</surname><given-names>P</given-names></name><name><surname>Yoshihara</surname><given-names>Y</given-names></name><name><surname>Mori</surname><given-names>K</given-names></name><name><surname>Gallatin</surname><given-names>WM</given-names></name><name><surname>Carp&#x000e9;n</surname><given-names>O</given-names></name><etal/></person-group>. <article-title>Binding of T lymphocytes to hippocampal neurons through ICAM-5</article-title>. (Telencephalin) and characterization of its interaction with the leukocyte integrin CD11a/CD18. <source>Eur J Immunol.</source> (<year>2000</year>) <volume>30</volume>:<fpage>810</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1002/1521-4141(200003)30:3&#x0003c;810::AID-IMMU810&#x0003e;3.0.CO;2-X</pub-id><?supplied-pmid 10741396?><pub-id pub-id-type="pmid">10741396</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campanero</surname><given-names>MR</given-names></name><name><surname>Del Pozo</surname><given-names>MA</given-names></name><name><surname>Arroyo</surname><given-names>AG</given-names></name><name><surname>S&#x000e1;nchez-Mateos</surname><given-names>P</given-names></name><name><surname>Hern&#x000e1;ndez-Caselles</surname><given-names>T</given-names></name><name><surname>Craig</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway</article-title>. <source>J Cell Biol</source>. (<year>1993</year>) <volume>123</volume>:<fpage>1007</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.123.4.1007</pub-id><?supplied-pmid 7901223?><pub-id pub-id-type="pmid">7901223</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wojcikiewicz</surname><given-names>EP</given-names></name><name><surname>Abdulreda</surname><given-names>MH</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Moy</surname><given-names>VT</given-names></name></person-group>. <article-title>Force spectroscopy of LFA-1 and its ligands, ICAM-1 and ICAM-2</article-title>. <source>Biomacromolecules</source>. (<year>2006</year>) <volume>7</volume>:<fpage>3188</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1021/bm060559c</pub-id><?supplied-pmid 17096550?><pub-id pub-id-type="pmid">17096550</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yakubenko</surname><given-names>VP</given-names></name><name><surname>Lishko</surname><given-names>VK</given-names></name><name><surname>Lam</surname><given-names>SCT</given-names></name><name><surname>Ugarova</surname><given-names>TP</given-names></name></person-group>
<article-title>A molecular basis for integrin &#x003b1; M &#x003b2; 2 ligand binding promiscuity</article-title>. <source>J Biol Chem</source>. (<year>2002</year>) <volume>277</volume>:<fpage>48635</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M208877200</pub-id><pub-id pub-id-type="pmid">12377763</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berton</surname><given-names>G</given-names></name><name><surname>Lowell</surname><given-names>CA</given-names></name></person-group>. <article-title>Integrin signalling in neutrophils and macrophages</article-title>. <source>Cell Signal</source>. (<year>1999</year>) <volume>11</volume>:<fpage>621</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/S0898-6568(99)00003-0</pub-id><?supplied-pmid 10530871?><pub-id pub-id-type="pmid">10530871</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altieri</surname><given-names>DC</given-names></name><name><surname>Agbanyo</surname><given-names>FR</given-names></name><name><surname>Plescia</surname><given-names>J</given-names></name><name><surname>Ginsberg</surname><given-names>MH</given-names></name><name><surname>Edgington</surname><given-names>TS</given-names></name><name><surname>Plow</surname><given-names>EF</given-names></name></person-group>. <article-title>A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1</article-title>. (CD11b/CD18). <source>J Biol Chem</source>. (<year>1990</year>) <volume>265</volume>:<fpage>12119</fpage>&#x02013;<lpage>22</lpage>. <?supplied-pmid 1973686?><pub-id pub-id-type="pmid">1973686</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lecoanet-Henchoz</surname><given-names>S</given-names></name><name><surname>Gauchat</surname><given-names>JF</given-names></name><name><surname>Aubry</surname><given-names>JP</given-names></name><name><surname>Graber</surname><given-names>P</given-names></name><name><surname>Life</surname><given-names>P</given-names></name><name><surname>Paul-Eugene</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18</article-title>. <source>Immunity</source>. (<year>1995</year>) <volume>3</volume>:<fpage>119</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/1074-7613(95)90164-7</pub-id><?supplied-pmid 7621072?><pub-id pub-id-type="pmid">7621072</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilsland</surname><given-names>CA</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group>. <article-title>The leukocyte integrin p150,95. (CD11c/CD18) as a receptor for IC3b. Activation by a heterologous beta subunit and localization of a ligand recognition site to the I domain</article-title>. <source>J Immunol.</source> (<year>1994</year>) <volume>152</volume>:<fpage>4582</fpage>&#x02013;<lpage>89</lpage>. <?supplied-pmid 7512600?><pub-id pub-id-type="pmid">7512600</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ihanus</surname><given-names>E</given-names></name><name><surname>Uotila</surname><given-names>LM</given-names></name><name><surname>Toivanen</surname><given-names>A</given-names></name><name><surname>Varis</surname><given-names>M</given-names></name><name><surname>Gahmberg</surname><given-names>CG</given-names></name></person-group>. <article-title>Red-Cell ICAM-4 is a ligand for the monocyte/macrophage integrin CD11c/CD18: characterization of the binding sites on ICAM-4</article-title>. <source>Blood</source>. (<year>2007</year>) <volume>109</volume>:<fpage>802</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2006-04-014878</pub-id><?supplied-pmid 16985175?><pub-id pub-id-type="pmid">16985175</pub-id></mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frick</surname><given-names>C</given-names></name><name><surname>Odermatt</surname><given-names>A</given-names></name><name><surname>Zen</surname><given-names>K</given-names></name><name><surname>Mandell</surname><given-names>KJ</given-names></name><name><surname>Edens</surname><given-names>H</given-names></name><name><surname>Portmann</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Interaction of ICAM-1 with B2-Integrin CD11c/CD18: characterization of a peptide ligand that mimics a putative binding site on domain D4 of ICAM-1</article-title>. <source>Eur J Immunol</source>. (<year>2005</year>) <volume>35</volume>:<fpage>3610</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1002/eji.200425914</pub-id><pub-id pub-id-type="pmid">16252253</pub-id></mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;ndor</surname><given-names>N</given-names></name><name><surname>Luk&#x000e1;csi</surname><given-names>S</given-names></name><name><surname>Ungai-Sal&#x000e1;nki</surname><given-names>R</given-names></name><name><surname>Orgov&#x000e1;n</surname><given-names>N</given-names></name><name><surname>Szab&#x000f3;</surname><given-names>B</given-names></name><name><surname>Horv&#x000e1;th</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>CD11c/CD18 dominates adhesion of human monocytes, macrophages and dendritic cells over CD11b/CD18</article-title>. <source>PLoS ONE.</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0163120</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0163120</pub-id><?supplied-pmid 27658051?><pub-id pub-id-type="pmid">27658051</pub-id></mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingalls</surname><given-names>RR</given-names></name><name><surname>Golenbock</surname><given-names>DT</given-names></name></person-group>. <article-title>CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide</article-title>. <source>J Exp Med</source>. (<year>1995</year>) <volume>181</volume>:<fpage>1473</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1084/jem.181.4.1473</pub-id><?supplied-pmid 7535339?><pub-id pub-id-type="pmid">7535339</pub-id></mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Leyton</surname><given-names>L</given-names></name><name><surname>Nham</surname><given-names>S</given-names></name></person-group>. <article-title>Characterization of AlphaX I-domain binding to thy-1</article-title>. <source>Biochem Biophys Res Commun</source>. (<year>2005</year>) <volume>331</volume>:<fpage>557</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2005.04.006</pub-id><?supplied-pmid 15850796?><pub-id pub-id-type="pmid">15850796</pub-id></mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gang</surname><given-names>J</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Nham</surname><given-names>SU</given-names></name></person-group>. <article-title>Identification of critical residues for plasminogen binding by the AlphaX I-domain of the Beta2 integrin, AlphaXbeta2</article-title>. <source>Mol Cells</source>. (<year>2007</year>) <volume>24</volume>:<fpage>240</fpage>&#x02013;<lpage>6</lpage>. <?supplied-pmid 17978577?><pub-id pub-id-type="pmid">17978577</pub-id></mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yakubenko</surname><given-names>VP</given-names></name><name><surname>Belevych</surname><given-names>N</given-names></name><name><surname>Mishchuk</surname><given-names>D</given-names></name><name><surname>Schurin</surname><given-names>A</given-names></name><name><surname>Lam</surname><given-names>SCT</given-names></name><name><surname>Ugarova</surname><given-names>TP</given-names></name></person-group>. <article-title>The role of integrin alpha D Beta2. (CD11d/CD18) in monocyte/macrophage migration</article-title>. <source>Exp Cell Res</source>. (<year>2008</year>) <volume>314</volume>:<fpage>2569</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2008.05.016</pub-id><?supplied-pmid 18621369?><pub-id pub-id-type="pmid">18621369</pub-id></mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieren</surname><given-names>MV</given-names></name><name><surname>Trong</surname><given-names>HL</given-names></name><name><surname>Wood</surname><given-names>CL</given-names></name><name><surname>Moore</surname><given-names>PF</given-names></name><name><surname>John</surname><given-names>T</given-names><suffix>St</suffix></name><name><surname>Staunton</surname><given-names>DE</given-names></name><etal/></person-group>. <article-title>A novel leukointegrin, Ad&#x003b2;2, binds preferentially to ICAM-3</article-title>. <source>Immunity.</source> (<year>1995</year>) <volume>3</volume>:<fpage>683</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/1074-7613(95)90058-6</pub-id><?supplied-pmid 8777714?><pub-id pub-id-type="pmid">8777714</pub-id></mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yakubenko</surname><given-names>VP</given-names></name><name><surname>Yadav</surname><given-names>SP</given-names></name><name><surname>Ugarova</surname><given-names>TP</given-names></name></person-group>. <article-title>Integrin AD&#x003b2;2, an adhesion receptor up-regulated on macrophage foam cells, exhibits multiligand-binding properties</article-title>. <source>Blood</source>. (<year>2006</year>) <volume>107</volume>:<fpage>1643</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2005-06-2509</pub-id><?supplied-pmid 16239428?><pub-id pub-id-type="pmid">16239428</pub-id></mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hemler</surname><given-names>ME</given-names></name></person-group>. <article-title>VLA proteins in the integrin family: structures, functions, and their role on leukocytes</article-title>. <source>Annual Rev Immunol</source>. (<year>1990</year>) <volume>8</volume>:<fpage>365</fpage>&#x02013;<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.iy.08.040190.002053</pub-id><?supplied-pmid 2188667?><pub-id pub-id-type="pmid">2188667</pub-id></mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahou</surname><given-names>WF</given-names></name><name><surname>Potter</surname><given-names>CL</given-names></name><name><surname>Mirza</surname><given-names>M</given-names></name></person-group>
<article-title>The VLA-2. (?2&#x003b2;1) I domain functions as a ligand-specific recognition sequence for endothelial cell attachment and spreading: molecular and functional characterization</article-title>. <source>Blood</source>. (<year>1994</year>) <volume>84</volume>:<fpage>3734</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1182/blood.V84.11.3734.bloodjournal84113734</pub-id><pub-id pub-id-type="pmid">7949129</pub-id></mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamata</surname><given-names>T</given-names></name><name><surname>Puzon</surname><given-names>W</given-names></name><name><surname>Takada</surname><given-names>Y</given-names></name></person-group>. <article-title>Identification of putative ligand binding sites within I domain of integrin alpha 2 Beta 1</article-title>. (VLA-2, CD49b/CD29). <source>J Biol Chem</source>. (<year>1994</year>) <volume>269</volume>:<fpage>9659</fpage>&#x02013;<lpage>63</lpage>. <?supplied-pmid 7511592?><pub-id pub-id-type="pmid">7511592</pub-id></mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>S</given-names></name><name><surname>Hu</surname><given-names>SY</given-names></name><name><surname>Wu</surname><given-names>SH</given-names></name><name><surname>Karmenyan</surname><given-names>A</given-names></name><name><surname>Chiou</surname><given-names>A</given-names></name></person-group>. <article-title>The interaction affinity between vascular cell adhesion molecule-1. (VCAM-1) and very late antigen-4. (VLA-4) analyzed by quantitative FRET</article-title>. <source>PLoS ONE.</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0121399</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0121399</pub-id><?supplied-pmid 25793408?><pub-id pub-id-type="pmid">25793408</pub-id></mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hart</surname><given-names>R</given-names></name><name><surname>Greaves</surname><given-names>DR</given-names></name></person-group>. <article-title>Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5</article-title>. <source>J Immunol</source>. (<year>2010</year>) <volume>185</volume>:<fpage>3728</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0902154</pub-id><?supplied-pmid 20720202?><pub-id pub-id-type="pmid">20720202</pub-id></mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pytela</surname><given-names>R</given-names></name><name><surname>Pierschbacher</surname><given-names>MD</given-names></name><name><surname>Ruoslahti</surname><given-names>E</given-names></name></person-group>. <article-title>Identification and isolation of a 140 Kd cell surface glycoprotein with properties expected of a fibronectin receptor</article-title>. <source>Cell</source>. (<year>1985</year>) <volume>40</volume>:<fpage>191</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(85)90322-8</pub-id><?supplied-pmid 3155652?><pub-id pub-id-type="pmid">3155652</pub-id></mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schottelius</surname><given-names>M</given-names></name><name><surname>Laufer</surname><given-names>B</given-names></name><name><surname>Kessler</surname><given-names>H</given-names></name><name><surname>Wester</surname><given-names>HJ</given-names></name></person-group>
<article-title>Ligands for mapping Av&#x003b2;3-integrin expression <italic>in vivo</italic></article-title>. <source>Accounts Chem Res</source>. (<year>2009</year>) <volume>42</volume>:<fpage>969</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1021/ar800243b</pub-id></mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>LM</given-names></name><name><surname>Lotz</surname><given-names>MM</given-names></name><name><surname>Mercurio</surname><given-names>AM</given-names></name></person-group>. <article-title>Inside-out integrin signaling in macrophages. Analysis of the role of the alpha 6A Beta 1 and Alpha 6B Beta 1 integrin variants in laminin adhesion by CDNA expression in an alpha 6 integrin-deficient macrophage cell line</article-title>. <source>J Biol Chem.</source> (<year>1993</year>) <volume>268</volume>:<fpage>11401</fpage>&#x02013;<lpage>8</lpage>. <?supplied-pmid 8496190?><pub-id pub-id-type="pmid">8496190</pub-id></mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JW</given-names></name><name><surname>Cheresh</surname><given-names>DA</given-names></name></person-group>
<article-title>Integrin. (?v&#x003b2;3)-ligand interaction: identification of a heterodimeric RGD binding site on the vitronectin receptor</article-title>. <source>J Biol Chem</source>. (<year>1990</year>) <volume>265</volume>:<fpage>2168</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">1688848</pub-id></mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumawat</surname><given-names>AK</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Mann</surname><given-names>EA</given-names></name><name><surname>Schridde</surname><given-names>A</given-names></name><name><surname>Finnemann</surname><given-names>SC</given-names></name><name><surname>Mowat</surname><given-names>AM</given-names></name></person-group>
<article-title>Expression and characterization of Av&#x003b2;5 integrin on intestinal macrophages</article-title>. <source>Eur J Immunol</source>. (<year>2018</year>) <volume>48</volume>:<fpage>1181</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201747318</pub-id><pub-id pub-id-type="pmid">29676784</pub-id></mixed-citation></ref><ref id="B81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nandrot</surname><given-names>EF</given-names></name><name><surname>Anand</surname><given-names>M</given-names></name><name><surname>Almeida</surname><given-names>D</given-names></name><name><surname>Atabai</surname><given-names>K</given-names></name><name><surname>Sheppard</surname><given-names>D</given-names></name><name><surname>Finnemann</surname><given-names>SC</given-names></name></person-group>
<article-title>Essential role for MFG-E8 as ligand for Av&#x003b2;5 integrin in diurnal retinal phagocytosis</article-title>. <source>Proc Natl Acad Sci USA</source>. (<year>2007</year>) <volume>104</volume>:<fpage>12005</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0704756104</pub-id><pub-id pub-id-type="pmid">17620600</pub-id></mixed-citation></ref><ref id="B82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JW</given-names></name><name><surname>Vestal</surname><given-names>DJ</given-names></name><name><surname>Irwin</surname><given-names>SV</given-names></name><name><surname>Burke</surname><given-names>TA</given-names></name><name><surname>Cheresh</surname><given-names>DA</given-names></name></person-group>
<article-title>Purification and functional characterization of integrin &#x003b1;V&#x003b2;5: an adhesion receptor for vitronectin</article-title>. <source>J Biol Chem</source>. (<year>1990</year>) <volume>265</volume>:<fpage>11008</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">1694173</pub-id></mixed-citation></ref><ref id="B83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmid</surname><given-names>MC</given-names></name><name><surname>Khan</surname><given-names>SQ</given-names></name><name><surname>Kaneda</surname><given-names>MM</given-names></name><name><surname>Pathria</surname><given-names>P</given-names></name><name><surname>Shepard</surname><given-names>R</given-names></name><name><surname>Louis</surname><given-names>TL</given-names></name><etal/></person-group>. <article-title>Integrin CD11b activation drives anti-tumor innate immunity</article-title>. <source>Nat Commun.</source> (<year>2018</year>) <volume>9</volume>:<fpage>5379</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-07387-4</pub-id><?supplied-pmid 30568188?><pub-id pub-id-type="pmid">30568188</pub-id></mixed-citation></ref><ref id="B84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Jin</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name></person-group>. <article-title>Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating syk and promoting degradation of MyD88 and TRIF via Cbl-B</article-title>. <source>Nat Immunol</source>. (<year>2010</year>) <volume>11</volume>:<fpage>734</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1038/ni.1908</pub-id><?supplied-pmid 20639876?><pub-id pub-id-type="pmid">20639876</pub-id></mixed-citation></ref><ref id="B85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name></person-group>. <article-title>Src promotes anti-inflammatory. (M2) macrophage generation via the IL-4/STAT6 pathway</article-title>. <source>Cytokine.</source> (<year>2018</year>) <volume>111</volume>:<fpage>209</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.cyto.2018.08.030</pub-id><?supplied-pmid 30176559?><pub-id pub-id-type="pmid">30176559</pub-id></mixed-citation></ref><ref id="B86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erler</surname><given-names>JT</given-names></name><name><surname>Bennewith</surname><given-names>KL</given-names></name><name><surname>Cox</surname><given-names>TR</given-names></name><name><surname>Lang</surname><given-names>G</given-names></name><name><surname>Bird</surname><given-names>D</given-names></name><name><surname>Koong</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic Niche</article-title>. <source>Cancer Cell</source>. (<year>2009</year>) <volume>15</volume>:<fpage>35</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2008.11.012</pub-id><?supplied-pmid 19111879?><pub-id pub-id-type="pmid">19111879</pub-id></mixed-citation></ref><ref id="B87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Xiong</surname><given-names>S</given-names></name><name><surname>Mao</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis</article-title>. <source>J Patho</source>. (<year>2016</year>) <volume>239</volume>:<fpage>484</fpage>&#x02013;<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1002/path.4747</pub-id><?supplied-pmid 27193093?><pub-id pub-id-type="pmid">27193093</pub-id></mixed-citation></ref><ref id="B88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>YP</given-names></name><name><surname>Martin</surname><given-names>LJ</given-names></name><name><surname>Hanna</surname><given-names>W</given-names></name><name><surname>Banerjee</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>N</given-names></name><name><surname>Fishell</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Growth factors and stromal matrix proteins associated with mammographic densities</article-title>. <source>Cancer Epidemiol Biomark Prevent</source>. (<year>2001</year>) <volume>10</volume>:<fpage>243</fpage>&#x02013;<lpage>8</lpage>. <?supplied-pmid 11303594?><pub-id pub-id-type="pmid">11303594</pub-id></mixed-citation></ref><ref id="B89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curran</surname><given-names>CS</given-names></name><name><surname>Keely</surname><given-names>PJ</given-names></name></person-group>. <article-title>Breast tumor and stromal cell responses to TGF-&#x003b2; and hypoxia in matrix deposition</article-title>. <source>Matrix Biol</source>. (<year>2013</year>) <volume>32</volume>:<fpage>95</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2012.11.016</pub-id><?supplied-pmid 23262216?><pub-id pub-id-type="pmid">23262216</pub-id></mixed-citation></ref><ref id="B90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>BH</given-names></name><name><surname>Shin</surname><given-names>SR</given-names></name><name><surname>Leijten</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>YC</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>JC</given-names></name><etal/></person-group>. <article-title>Integrin-mediated interactions control macrophage polarization in 3D hydrogels</article-title>. <source>Adv Healthcare Mater.</source> (<year>2017</year>) <volume>6</volume>:<fpage>21</fpage>. <pub-id pub-id-type="doi">10.1002/adhm.201700289</pub-id><?supplied-pmid 28782184?><pub-id pub-id-type="pmid">28782184</pub-id></mixed-citation></ref><ref id="B91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pakshir</surname><given-names>P</given-names></name><name><surname>Alizadehgiashi</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>B</given-names></name><name><surname>Coelho</surname><given-names>NM</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Gong</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>Dynamic fibroblast contractions attract remote macrophages in fibrillar collagen matrix</article-title>. <source>Nat Commun.</source> (<year>2019</year>) <volume>10</volume>:<fpage>1850</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-019-09709-6</pub-id><pub-id pub-id-type="pmid">31015429</pub-id></mixed-citation></ref><ref id="B92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gowen</surname><given-names>BB</given-names></name><name><surname>Borg</surname><given-names>TK</given-names></name><name><surname>Ghaffar</surname><given-names>A</given-names></name><name><surname>Mayer</surname><given-names>EP</given-names></name></person-group>. <article-title>Selective adhesion of macrophages to denatured forms of type I collagen is mediated by scavenger receptors</article-title>. <source>Matrix Biol</source>. (<year>2000</year>) <volume>19</volume>:<fpage>61</fpage>&#x02013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/S0945-053X(99)00052-9</pub-id><?supplied-pmid 10686426?><pub-id pub-id-type="pmid">10686426</pub-id></mixed-citation></ref><ref id="B93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janabi</surname><given-names>M</given-names></name><name><surname>Yamashita</surname><given-names>S</given-names></name><name><surname>Hirano</surname><given-names>K</given-names></name><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Sakai</surname><given-names>N</given-names></name><name><surname>Hiraoka</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Reduced adhesion of monocyte-derived macrophages from CD36-deficient patients to type I collagen</article-title>. <source>Biochem Biophys Res Commun</source>. (<year>2001</year>) <volume>283</volume>:<fpage>26</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.2001.4718</pub-id><?supplied-pmid 11322762?><pub-id pub-id-type="pmid">11322762</pub-id></mixed-citation></ref><ref id="B94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazur</surname><given-names>A</given-names></name><name><surname>Holthoff</surname><given-names>E</given-names></name><name><surname>Vadali</surname><given-names>S</given-names></name><name><surname>Kelly</surname><given-names>T</given-names></name><name><surname>Post</surname><given-names>SR</given-names></name></person-group>. <article-title>Cleavage of type I collagen by fibroblast activation protein-&#x003b1; enhances class a scavenger receptor mediated macrophage adhesion</article-title>. <source>PLoS ONE.</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0150287</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0150287</pub-id><?supplied-pmid 26934296?><pub-id pub-id-type="pmid">26934296</pub-id></mixed-citation></ref><ref id="B95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yakubenko</surname><given-names>VP</given-names></name><name><surname>Bhattacharjee</surname><given-names>A</given-names></name><name><surname>Pluskota</surname><given-names>E</given-names></name><name><surname>Cathcart</surname><given-names>MK</given-names></name></person-group>. <article-title>Am&#x003b2;2 integrin activation prevents alternative activation of human and murine macrophages and impedes foam cell formation</article-title>. <source>Circulation Res</source>. (<year>2011</year>) <volume>108</volume>:<fpage>544</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.231803</pub-id><?supplied-pmid 21252155?><pub-id pub-id-type="pmid">21252155</pub-id></mixed-citation></ref><ref id="B96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagemann</surname><given-names>T</given-names></name><name><surname>Wilson</surname><given-names>J</given-names></name><name><surname>Burke</surname><given-names>F</given-names></name><name><surname>Kulbe</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>NF</given-names></name><name><surname>Pl&#x000fc;ddemann</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype</article-title>. <source>J Immunol</source>. (<year>2006</year>) <volume>176</volume>:<fpage>5023</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.176.8.5023</pub-id><?supplied-pmid 16585599?><pub-id pub-id-type="pmid">16585599</pub-id></mixed-citation></ref><ref id="B97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neyen</surname><given-names>C</given-names></name><name><surname>Pl&#x000fc;ddemann</surname><given-names>A</given-names></name><name><surname>Mukhopadhyay</surname><given-names>S</given-names></name><name><surname>Maniati</surname><given-names>E</given-names></name><name><surname>Bossard</surname><given-names>M</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Macrophage scavenger receptor A promotes tumor progression in murine models of ovarian and pancreatic cancer</article-title>. <source>J Immunol</source>. (<year>2013</year>) <volume>190</volume>:<fpage>3798</fpage>&#x02013;<lpage>805</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1203194</pub-id><?supplied-pmid 23447685?><pub-id pub-id-type="pmid">23447685</pub-id></mixed-citation></ref><ref id="B98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonov</surname><given-names>AS</given-names></name><name><surname>Antonova</surname><given-names>GN</given-names></name><name><surname>Munn</surname><given-names>DH</given-names></name><name><surname>Mivechi</surname><given-names>N</given-names></name><name><surname>Lucas</surname><given-names>R</given-names></name><name><surname>Catravas</surname><given-names>JD</given-names></name><etal/></person-group>
<article-title>AV&#x003b2;3 integrin regulates macrophage inflammatory responses via PI3 kinase/Akt-dependent NF-?B activation</article-title>. <source>J Cell Physiol</source>. (<year>2011</year>) <volume>226</volume>:<fpage>469</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.22356</pub-id><pub-id pub-id-type="pmid">20672329</pub-id></mixed-citation></ref><ref id="B99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Flores-Borja</surname><given-names>F</given-names></name><name><surname>Nassiri</surname><given-names>S</given-names></name><name><surname>Miranda</surname><given-names>E</given-names></name><name><surname>Lawler</surname><given-names>K</given-names></name><name><surname>Grigoriadis</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Integrin-mediated macrophage adhesion promotes lymphovascular dissemination in breast cancer</article-title>. <source>Cell Rep</source>. (<year>2019</year>) <volume>27</volume>:<fpage>1967</fpage>&#x02013;<lpage>78.e4</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.04.076</pub-id><?supplied-pmid 31091437?><pub-id pub-id-type="pmid">31091437</pub-id></mixed-citation></ref><ref id="B100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Digiacomo</surname><given-names>G</given-names></name><name><surname>Tusa</surname><given-names>I</given-names></name><name><surname>Bacci</surname><given-names>M</given-names></name><name><surname>Cipolleschi</surname><given-names>MG</given-names></name><name><surname>Sbarba</surname><given-names>PD</given-names></name><name><surname>Rovida</surname><given-names>E</given-names></name></person-group>. <article-title>Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway</article-title>. <source>Cell Adhesion Migrat</source>. (<year>2017</year>) <volume>11</volume>:<fpage>327</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1080/19336918.2016.1221566</pub-id><?supplied-pmid 27588738?><pub-id pub-id-type="pmid">27588738</pub-id></mixed-citation></ref><ref id="B101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollard</surname><given-names>JW</given-names></name></person-group>. <article-title>Macrophages define the invasive microenvironment in breast cancer</article-title>. <source>J Leukocyte Biol</source>. (<year>2008</year>) <volume>84</volume>:<fpage>623</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.1107762</pub-id><?supplied-pmid 18467655?><pub-id pub-id-type="pmid">18467655</pub-id></mixed-citation></ref><ref id="B102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zajd</surname><given-names>CM</given-names></name><name><surname>Ziemba</surname><given-names>AM</given-names></name><name><surname>Miralles</surname><given-names>GM</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Feustel</surname><given-names>PJ</given-names></name><name><surname>Dunn</surname><given-names>SM</given-names></name><etal/></person-group>
<article-title>Bone marrow-derived and elicited peritoneal macrophages are not created equal: the questions asked dictate the cell type used</article-title>. <source>Front Immunol.</source> (<year>2020</year>) <volume>11</volume>:<fpage>269</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2020.00269</pub-id><pub-id pub-id-type="pmid">32153579</pub-id></mixed-citation></ref><ref id="B103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>AYH</given-names></name><name><surname>Tu</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Oursler</surname><given-names>MJ</given-names></name><name><surname>Qu</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Comparative characterization of osteoclasts derived from murine bone marrow macrophages and RAW 264.7 cells using quantitative proteomics</article-title>. <source>JBMR Plus.</source> (<year>2018</year>) <volume>2</volume>:<fpage>328</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1002/jbm4.10058</pub-id><?supplied-pmid 30460336?><pub-id pub-id-type="pmid">30460336</pub-id></mixed-citation></ref><ref id="B104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schildberger</surname><given-names>A</given-names></name><name><surname>Eva</surname><given-names>R</given-names></name><name><surname>Tanja</surname><given-names>E</given-names></name><name><surname>Katharina</surname><given-names>S</given-names></name><name><surname>Viktoria</surname><given-names>W</given-names></name></person-group>. <article-title>Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide</article-title>. <source>Mediat Inflamm.</source> (<year>2013</year>). <volume>2013</volume>:<fpage>697972</fpage>. <pub-id pub-id-type="doi">10.1155/2013/697972</pub-id><?supplied-pmid 23818743?><pub-id pub-id-type="pmid">23818743</pub-id></mixed-citation></ref><ref id="B105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiratori</surname><given-names>H</given-names></name><name><surname>Feinweber</surname><given-names>C</given-names></name><name><surname>Luckhardt</surname><given-names>S</given-names></name><name><surname>Linke</surname><given-names>B</given-names></name><name><surname>Resch</surname><given-names>E</given-names></name><name><surname>Geisslinger</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize <italic>in vitro</italic></article-title>. <source>Mol Immunol.</source> (<year>2017</year>) <volume>88</volume>:<fpage>58</fpage>&#x02013;<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1016/j.molimm.2017.05.027</pub-id><?supplied-pmid 28600970?><pub-id pub-id-type="pmid">28600970</pub-id></mixed-citation></ref><ref id="B106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingersoll</surname><given-names>MA</given-names></name><name><surname>Spanbroek</surname><given-names>R</given-names></name><name><surname>Lottaz</surname><given-names>C</given-names></name><name><surname>Gautier</surname><given-names>EL</given-names></name><name><surname>Frankenberger</surname><given-names>M</given-names></name><name><surname>Hoffmann</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Comparison of gene expression profiles between human and mouse monocyte subsets</article-title>. <source>Blood.</source> (<year>2010</year>) <volume>115</volume>:<fpage>e10</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2009-07-235028</pub-id><?supplied-pmid 19965649?><pub-id pub-id-type="pmid">19965649</pub-id></mixed-citation></ref><ref id="B107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>FO</given-names></name><name><surname>Helming</surname><given-names>L</given-names></name><name><surname>Milde</surname><given-names>R</given-names></name><name><surname>Varin</surname><given-names>A</given-names></name><name><surname>Melgert</surname><given-names>BN</given-names></name><name><surname>Draijer</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences</article-title>. <source>Blood</source>. (<year>2013</year>) <volume>121</volume>:<fpage>e57</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1182/blood-2012-06-436212</pub-id><?supplied-pmid 23293084?><pub-id pub-id-type="pmid">23293084</pub-id></mixed-citation></ref><ref id="B108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiller</surname><given-names>KL</given-names></name><name><surname>Wrona</surname><given-names>EA</given-names></name><name><surname>Romero-Torres</surname><given-names>S</given-names></name><name><surname>Pallotta</surname><given-names>I</given-names></name><name><surname>Graney</surname><given-names>PL</given-names></name><name><surname>Witherel</surname><given-names>CE</given-names></name><etal/></person-group>. <article-title>Differential gene expression in human, murine, and cell line-derived macrophages upon polarization</article-title>. <source>Exp Cell Res</source>. (<year>2016</year>) <volume>347</volume>:<fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2015.10.017</pub-id><?supplied-pmid 26500109?><pub-id pub-id-type="pmid">26500109</pub-id></mixed-citation></ref><ref id="B109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>TM</given-names></name></person-group>. <article-title>Discovering macrophage functions using <italic>in vivo</italic> optical imaging techniques</article-title>. <source>Front Immunol.</source> (<year>2018</year>) <volume>9</volume>:<fpage>502</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.00502</pub-id><?supplied-pmid 29599778?><pub-id pub-id-type="pmid">29599778</pub-id></mixed-citation></ref><ref id="B110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rostam</surname><given-names>HM</given-names></name><name><surname>Paul</surname><given-names>MR</given-names></name><name><surname>Morgan</surname><given-names>R</given-names></name><name><surname>Alexander</surname><given-names>N</given-names></name><name><surname>Amir</surname><given-names>M</given-names></name></person-group>. <article-title>Image based machine learning for identification of macrophage subsets</article-title>. <source>Sci Rep.</source> (<year>2017</year>) <volume>7</volume>:<fpage>3521</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-03780-z</pub-id><?supplied-pmid 28615717?><pub-id pub-id-type="pmid">28615717</pub-id></mixed-citation></ref><ref id="B111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebelo</surname><given-names>SP</given-names></name><name><surname>Pinto</surname><given-names>C</given-names></name><name><surname>Martins</surname><given-names>TR</given-names></name><name><surname>Harrer</surname><given-names>N</given-names></name><name><surname>Estrada</surname><given-names>MF</given-names></name><name><surname>Loza-Alvarez</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>3D-3-culture: a tool to unveil macrophage plasticity in the tumour microenvironment</article-title>. <source>Biomaterials</source>. (<year>2018</year>) <volume>163</volume>:<fpage>185</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.02.030</pub-id><?supplied-pmid 29477032?><pub-id pub-id-type="pmid">29477032</pub-id></mixed-citation></ref><ref id="B112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irimia</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group>. <article-title>Inflammation-on-a-chip: probing the immune system <italic>ex vivo</italic></article-title>. <source>Trends Biotechnol</source>. (<year>2018</year>) <volume>36</volume>:<fpage>923</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2018.03.011</pub-id><?supplied-pmid 29728272?><pub-id pub-id-type="pmid">29728272</pub-id></mixed-citation></ref><ref id="B113"><label>113.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boussommier-Calleja</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>MB</given-names></name><name><surname>Wong</surname><given-names>SC</given-names></name><name><surname>Kamm</surname><given-names>RD</given-names></name></person-group>. <article-title>Microfluidics: a new tool for modeling cancer&#x02013;immune interactions</article-title>. <source>Trends Cancer</source>. (<year>2016</year>) <volume>2</volume>:<fpage>6</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.trecan.2015.12.003</pub-id><?supplied-pmid 26858990?><pub-id pub-id-type="pmid">26858990</pub-id></mixed-citation></ref><ref id="B114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meshik</surname><given-names>X</given-names></name><name><surname>O'Neill</surname><given-names>PR</given-names></name><name><surname>Gautam</surname><given-names>N</given-names></name></person-group>. <article-title>Physical plasma membrane perturbation using subcellular optogenetics drives integrin-activated cell migration</article-title>. <source>ACS Synthetic Biol</source>. (<year>2019</year>) <volume>8</volume>:<fpage>498</fpage>&#x02013;<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1021/acssynbio.8b00356</pub-id><?supplied-pmid 30764607?><pub-id pub-id-type="pmid">30764607</pub-id></mixed-citation></ref><ref id="B115"><label>115.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pertz</surname><given-names>O</given-names></name><name><surname>Hodgson</surname><given-names>L</given-names></name><name><surname>Klemke</surname><given-names>RL</given-names></name><name><surname>Hahn</surname><given-names>KM</given-names></name></person-group>. <article-title>Spatiotemporal dynamics of RhoA activity in migrating cells</article-title>. <source>Nature</source>. (<year>2006</year>) <volume>440</volume>:<fpage>1069</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1038/nature04665</pub-id><?supplied-pmid 16547516?><pub-id pub-id-type="pmid">16547516</pub-id></mixed-citation></ref><ref id="B116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dagliyan</surname><given-names>O</given-names></name><name><surname>Tarnawski</surname><given-names>M</given-names></name><name><surname>Chu</surname><given-names>PH</given-names></name><name><surname>Shirvanyants</surname><given-names>D</given-names></name><name><surname>Schlichting</surname><given-names>I</given-names></name><name><surname>Dokholyan</surname><given-names>NV</given-names></name><etal/></person-group>. <article-title>Engineering extrinsic disorder to control protein activity in living cells</article-title>. <source>Science</source>. (<year>2016</year>) <volume>354</volume>:<fpage>1441</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1126/science.aah3404</pub-id><?supplied-pmid 27980211?><pub-id pub-id-type="pmid">27980211</pub-id></mixed-citation></ref><ref id="B117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coste</surname><given-names>A</given-names></name><name><surname>Oktay</surname><given-names>MH</given-names></name><name><surname>Condeelis</surname><given-names>JS</given-names></name><name><surname>Entenberg</surname><given-names>D</given-names></name></person-group>. <article-title>Intravital imaging techniques for biomedical and clinical research</article-title>. <source>Cytometry.</source> (<year>2019</year>) <volume>97</volume>:<fpage>448</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1002/cyto.a.23963</pub-id><?supplied-pmid 31889408?><pub-id pub-id-type="pmid">31889408</pub-id></mixed-citation></ref><ref id="B118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kedrin</surname><given-names>D</given-names></name><name><surname>Gligorijevic</surname><given-names>B</given-names></name><name><surname>Wyckoff</surname><given-names>J</given-names></name><name><surname>Verkhusha</surname><given-names>VV</given-names></name><name><surname>Condeelis</surname><given-names>J</given-names></name><name><surname>Segall</surname><given-names>JE</given-names></name><etal/></person-group>. <article-title>Intravital imaging of metastatic behavior through a mammary imaging window</article-title>. <source>Nat Methods</source>. (<year>2008</year>) <volume>5</volume>:<fpage>1019</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1269</pub-id><?supplied-pmid 18997781?><pub-id pub-id-type="pmid">18997781</pub-id></mixed-citation></ref><ref id="B119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szulczewski</surname><given-names>JM</given-names></name><name><surname>Inman</surname><given-names>DR</given-names></name><name><surname>Entenberg</surname><given-names>D</given-names></name><name><surname>Ponik</surname><given-names>SM</given-names></name><name><surname>Aguirre-Ghiso</surname><given-names>J</given-names></name><name><surname>Castracane</surname><given-names>J</given-names></name><etal/></person-group>. <article-title><italic>In vivo</italic> visualization of stromal macrophages via label-free FLIM-based metabolite imaging</article-title>. <source>Sci Rep.</source> (<year>2016</year>) <volume>6</volume>:<fpage>25086</fpage>. <pub-id pub-id-type="doi">10.1038/srep25086</pub-id><?supplied-pmid 27220760?><pub-id pub-id-type="pmid">27220760</pub-id></mixed-citation></ref><ref id="B120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>HA</given-names></name><name><surname>Loschko</surname><given-names>J</given-names></name><name><surname>Karssemeijer</surname><given-names>RA</given-names></name><name><surname>Escolano</surname><given-names>A</given-names></name><name><surname>Meredith</surname><given-names>MM</given-names></name><name><surname>Mucida</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Intestinal monocytes and macrophages are required for T cell polarization in response to citrobacter rodentium</article-title>. <source>J Exp Med</source>. (<year>2013</year>) <volume>210</volume>:<fpage>2025</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20130903</pub-id><?supplied-pmid 24043764?><pub-id pub-id-type="pmid">24043764</pub-id></mixed-citation></ref><ref id="B121"><label>121.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harney</surname><given-names>AS</given-names></name><name><surname>Arwert</surname><given-names>EN</given-names></name><name><surname>Entenberg</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><name><surname>Qian</surname><given-names>BZ</given-names></name><etal/></person-group>. <article-title>Real-time imaging reveals local, transient vascular permeability, and tumor cell intravasation stimulated by TIE2hi macrophage&#x02013;derived VEGFA</article-title>. <source>Cancer Discov</source>. (<year>2015</year>) <volume>5</volume>:<fpage>932</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1158/2159-8290.CD-15-0012</pub-id><?supplied-pmid 26269515?><pub-id pub-id-type="pmid">26269515</pub-id></mixed-citation></ref><ref id="B122"><label>122.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Entenberg</surname><given-names>D</given-names></name><name><surname>Voiculescu</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>P</given-names></name><name><surname>Borriello</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Karagiannis</surname><given-names>GS</given-names></name><etal/></person-group>. <article-title>A permanent window for the murine lung enables high-resolution imaging of cancer metastasis</article-title>. <source>Nat Methods</source>. (<year>2018</year>) <volume>15</volume>:<fpage>73</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.4511</pub-id><?supplied-pmid 29176592?><pub-id pub-id-type="pmid">29176592</pub-id></mixed-citation></ref><ref id="B123"><label>123.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berezin</surname><given-names>MY</given-names></name><name><surname>Achilefu</surname><given-names>S</given-names></name></person-group>. <article-title>Fluorescence lifetime measurements and biological imaging</article-title>. <source>Chem Rev</source>. (<year>2010</year>) <volume>110</volume>:<fpage>2641</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1021/cr900343z</pub-id><?supplied-pmid 20356094?><pub-id pub-id-type="pmid">20356094</pub-id></mixed-citation></ref><ref id="B124"><label>124.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lakowicz</surname><given-names>JR</given-names></name><name><surname>Szmacinski</surname><given-names>H</given-names></name><name><surname>Nowaczyk</surname><given-names>K</given-names></name><name><surname>Johnson</surname><given-names>ML</given-names></name></person-group>. <article-title>Fluorescence lifetime imaging of free and protein-bound NADH</article-title>. <source>Biochemistry</source>. (<year>1992</year>) <volume>89</volume>:<fpage>1271</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.4.1271</pub-id><?supplied-pmid 1741380?><pub-id pub-id-type="pmid">1741380</pub-id></mixed-citation></ref><ref id="B125"><label>125.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfonso-Garc&#x000ed;a</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>TD</given-names></name><name><surname>Datta</surname><given-names>R</given-names></name><name><surname>Luu</surname><given-names>TU</given-names></name><name><surname>Gratton</surname><given-names>E</given-names></name><name><surname>Potma</surname><given-names>EO</given-names></name><etal/></person-group>. <article-title>Label-free identification of macrophage phenotype by fluorescence lifetime imaging microscopy</article-title>. <source>J Biomed Optics</source>. (<year>2016</year>) <volume>21</volume>:<fpage>046005</fpage>. <pub-id pub-id-type="doi">10.1117/1.JBO.21.4.046005</pub-id><?supplied-pmid 27086689?><pub-id pub-id-type="pmid">27086689</pub-id></mixed-citation></ref><ref id="B126"><label>126.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>S</given-names></name><name><surname>Deng</surname><given-names>L</given-names></name><name><surname>Liao</surname><given-names>X</given-names></name><name><surname>Nie</surname><given-names>L</given-names></name><name><surname>Qi</surname><given-names>F</given-names></name><name><surname>Jin</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Tumor-associated macrophages promote bladder tumor growth through PI3K/AKT signal induced by collagen</article-title>. <source>Cancer Sci</source>. (<year>2019</year>) <volume>110</volume>:<fpage>2110</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/cas.14078</pub-id><?supplied-pmid 31120174?><pub-id pub-id-type="pmid">31120174</pub-id></mixed-citation></ref><ref id="B127"><label>127.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covarrubias</surname><given-names>AJ</given-names></name><name><surname>Aksoylar</surname><given-names>HI</given-names></name><name><surname>Horng</surname><given-names>T</given-names></name></person-group>. <article-title>Control of macrophage metabolism and activation by MTOR and Akt Signaling</article-title>. <source>Semin Immunol</source>. (<year>2015</year>). <volume>27</volume>:<fpage>286</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.smim.2015.08.001</pub-id><?supplied-pmid 26360589?><pub-id pub-id-type="pmid">26360589</pub-id></mixed-citation></ref></ref-list></back></article>